{
  "$schema": "folio-library-document/v1",
  "id": "10665-324745",
  "title": "Technical update: considerations for developing a monitoring and evaluation framework for viral load testing: collecting and using data for scale-up and outcomes",
  "variant": "pdf",
  "pages": 56,
  "tocSource": "undetermined",
  "tocMethod": "contents",
  "toc": [],
  "sections": [
    {
      "id": "page-001",
      "number": null,
      "title": "Page 1",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 1,
      "labelStart": "55",
      "labelEnd": "55",
      "words": 24,
      "summary": {
        "text": "The cover page of the April 2019 WHO technical update on developing a monitoring and evaluation framework for viral load testing.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "CONSIDERATIONS FOR DEVELOPING A MONITORING AND EVALUATION FRAMEWORK FOR VIRAL LOAD TESTING APRIL 2019 TECHNICAL UPDATE COLLECTING AND USING DATA FOR SCALE-UP AND OUTCOMES",
      "extractCut": false,
      "blocks": [
        "library/10665-324745/blocks/prose-page-001",
        "library/10665-324745/blocks/figure-img-p001-1"
      ]
    },
    {
      "id": "page-002",
      "number": null,
      "title": "Page 2",
      "level": 1,
      "pageStart": 2,
      "pageEnd": 2,
      "labelStart": "b",
      "labelEnd": "b",
      "words": 503,
      "summary": {
        "text": "The copyright and cataloguing page of the 2019 WHO publication on viral load testing monitoring and evaluation, with document number, licence terms, suggested citation and disclaimers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "creative commons",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "suggested citation",
          "heading": false
        },
        {
          "term": "licence",
          "heading": false
        },
        {
          "term": "cds hiv",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "health organization",
          "heading": false
        },
        {
          "term": "world health",
          "heading": false
        }
      ],
      "extract": "Considerations for developing a monitoring and evaluation framework for viral load testing WHO/CDS/HIV/19.5 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-002"
      ]
    },
    {
      "id": "page-003",
      "number": null,
      "title": "Page 3",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 3,
      "labelStart": "1",
      "labelEnd": "1",
      "words": 17,
      "summary": {
        "text": "The inner title page of the April 2019 technical update on a monitoring and evaluation framework for viral load testing.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "CONSIDERATIONS FOR DEVELOPING A MONITORING AND EVALUATION FRAMEWORK FOR VIRAL LOAD TESTING TECHNICAL UPDATE – APRIL 2019",
      "extractCut": false,
      "blocks": [
        "library/10665-324745/blocks/prose-page-003"
      ]
    },
    {
      "id": "page-004",
      "number": null,
      "title": "Page 4",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": "2",
      "labelEnd": "2",
      "words": 858,
      "summary": {
        "text": "The table of contents, listing sections on assessing monitoring systems, indicators and service quality evaluation, and annexes with tools such as a logic model and assessment checklists.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "evaluation systems",
          "heading": false
        },
        {
          "term": "scale-up",
          "heading": false
        },
        {
          "term": "annex",
          "heading": false
        }
      ],
      "extract": "CONTENTS Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Executive summary . . . . . . . . . . . . . . . . . . . . . . . .",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-004"
      ]
    },
    {
      "id": "page-005",
      "number": null,
      "title": "Page 5",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": "3",
      "labelEnd": "3",
      "words": 166,
      "summary": {
        "text": "Acknowledges WHO and the PEPFAR Viral Load Working Group as authors, lists collaborating organizations, and notes PEPFAR funding through the US CDC.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "united states",
          "heading": false
        },
        {
          "term": "states centers",
          "heading": false
        },
        {
          "term": "pepfar viral",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load working",
          "heading": false
        },
        {
          "term": "disease control",
          "heading": false
        }
      ],
      "extract": "ACKNOWLEDGEMENTS WHO and the PEPFAR Viral Load Working Group prepared this publication. Nadia Solehdin (CDC), Rituparna Pati (CDC), Laura N. Broyles (CDC), Dianna Edgil (USAID), Lara Vojnov (WHO). Collaborators WHO United States Centers for Disease Control and Prevention Office of the United States Global AIDS Coordinator and Health Diplomacy African Society for Laboratory Medicine United States Agency for",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-005"
      ]
    },
    {
      "id": "page-006",
      "number": null,
      "title": "Page 6",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 6,
      "labelStart": "4",
      "labelEnd": "4",
      "words": 28,
      "summary": {
        "text": "A short list of abbreviations used in the publication, such as DHIS2, MER, PEPFAR and UNAIDS.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pepfar",
          "heading": false
        },
        {
          "term": "mer",
          "heading": false
        },
        {
          "term": "president",
          "heading": false
        }
      ],
      "extract": "ABBREVIATIONS DHIS2 District Health Information System MER PEPFAR Monitoring, Evaluation and Reporting PEPFAR United States President’s Emergency Plan for AIDS Relief UNAIDS Joint United Nations Programme on HIV/AIDS",
      "extractCut": false,
      "blocks": [
        "library/10665-324745/blocks/prose-page-006"
      ]
    },
    {
      "id": "page-007",
      "number": null,
      "title": "Page 7",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 7,
      "labelStart": "5",
      "labelEnd": "5",
      "words": 368,
      "summary": {
        "text": "Summarises the publication's purpose of helping countries build national monitoring and evaluation plans as viral load testing is scaled up towards the target of 90% viral suppression. It outlines the three sections, covering assessment of data systems, indicators along the testing cascade and follow-up of people with unsuppressed viral load, and service quality assessment and evaluation.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "routine viral",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "tools",
          "heading": false
        },
        {
          "term": "evaluation",
          "heading": false
        },
        {
          "term": "suppressed",
          "heading": false
        }
      ],
      "extract": "EXECUTIVE SUMMARY The WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommend viral load as the preferred monitoring approach to detect and confirm the failure of antiretroviral therapy. As countries invest in scaling up of routine viral load testing, measuring the impact of and progress towards achieving the UNAIDS target that 90% of people receiving",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-007"
      ]
    },
    {
      "id": "page-008",
      "number": null,
      "title": "Page 8",
      "level": 1,
      "pageStart": 8,
      "pageEnd": 8,
      "labelStart": "6",
      "labelEnd": "6",
      "words": 526,
      "summary": {
        "text": "Introduces viral load testing as a system that depends on sample transport, data systems and clinical follow-up as well as laboratory work, and explains the need for coordinated monitoring and evaluation plans. It notes how viral load data inform both patient care and programme performance. A figure lists global HIV cascade indicators linked to the 90-90-90 targets.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        },
        {
          "term": "viral suppression",
          "heading": false
        },
        {
          "term": "people living",
          "heading": false
        },
        {
          "term": "hiv receiving",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        }
      ],
      "extract": "INTRODUCTION Monitoring the continuum of the HIV response is critical for ensuring high quality of care and optimal clinical outcomes for people living with HIV. The recent scale-up of routine viral load monitoring has played an integral role in tracking both the individual response to antiretroviral therapy and performance towards achieving programmatic goals. Viral load testing encompasses more than conducting the",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-008",
        "library/10665-324745/blocks/figure-vfig-p008"
      ]
    },
    {
      "id": "page-009",
      "number": null,
      "title": "Page 9",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "7",
      "labelEnd": "7",
      "words": 287,
      "summary": {
        "text": "Explains the UNAIDS 90-90-90 targets and why process, outcome and quality indicators beyond the global set are needed to track progress on viral suppression. It then sets out the publication's main objective and the topics it covers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load implementation",
          "heading": false
        },
        {
          "term": "measure progress",
          "heading": false
        },
        {
          "term": "unaids targets",
          "heading": false
        },
        {
          "term": "towards achieving",
          "heading": false
        }
      ],
      "extract": "Introduction progress in achieving the ambitious UNAIDS 90–90–90 targets: 90% of the people living with HIV know their HIV status, 90% of the people who know their HIV-positive status are receiving antiretroviral therapy and 90% of the people receiving antiretroviral therapy have suppressed viral loads. Fig. 1 illustrates the HIV cascade, the key cascade indicators and the UNAIDS 90–90–90 targets. Although the WHO",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-009"
      ]
    },
    {
      "id": "page-010",
      "number": null,
      "title": "Page 10",
      "level": 1,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": "8",
      "labelEnd": "8",
      "words": 720,
      "summary": {
        "text": "Opens section 1 by stressing that assessing existing data collection and reporting systems is an early step in scaling up viral load testing. It recommends reviewing the wider HIV monitoring system where possible, mapping how data flow between facilities, transport networks and laboratories. The text refers to WHO guidance on person-centred patient monitoring for further detail.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load data",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "testing cascades",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "received viral",
          "heading": false
        }
      ],
      "extract": "1. ASSESSING AND STRENGTHENING VIRAL LOAD MONITORING AND EVALUATION SYSTEMS Assessing the current data collection, reporting and management systems in place for implementing viral load testing is one of the first steps in ensuring that countries have robust systems for high-quality viral load testing data. This assessment of the monitoring and evaluation systems will provide a review of how systems collect and move",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-010"
      ]
    },
    {
      "id": "page-011",
      "number": null,
      "title": "Page 11",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": "9",
      "labelEnd": "9",
      "words": 473,
      "summary": {
        "text": "Describes mapping the sample transport and results return network, using a Ugandan model of motorbike riders and laboratory hubs as an example. It suggests programmes record which monitoring tools are used at each step and adapt an example process map.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "lab hub",
          "heading": false
        },
        {
          "term": "catchment area",
          "heading": false
        },
        {
          "term": "evaluation tools",
          "heading": false
        },
        {
          "term": "transport network",
          "heading": false
        },
        {
          "term": "central lab",
          "heading": false
        }
      ],
      "extract": "Fig. 2. Example of a map of a sample transport network and the return of results for viral load testing molecular laboratories for viral load testing. The network for transporting sample and results is an especially complex system, and monitoring and evaluation tools are generally required at every step. One successful sample transport model from Uganda involves a sample transport network in which motorbike riders",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-011",
        "library/10665-324745/blocks/figure-img-p011-9",
        "library/10665-324745/blocks/figure-img-p011-10",
        "library/10665-324745/blocks/figure-img-p011-11",
        "library/10665-324745/blocks/figure-img-p011-12",
        "library/10665-324745/blocks/figure-img-p011-16",
        "library/10665-324745/blocks/figure-img-p011-17",
        "library/10665-324745/blocks/figure-img-p011-21",
        "library/10665-324745/blocks/figure-vfig-p011"
      ]
    },
    {
      "id": "page-012",
      "number": null,
      "title": "Page 12",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": "10",
      "labelEnd": "10",
      "words": 704,
      "summary": {
        "text": "Shows an example of standard operating procedures for capturing and analysing viral load data and lists the tools needed, such as requisition forms, sample logbooks, result forms, high viral load registers, patient records, DHIS2 and laboratory information systems. It advises reviewing how these tools collect and link data during an assessment.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load requisition",
          "heading": false
        },
        {
          "term": "load logbook",
          "heading": false
        },
        {
          "term": "load sample",
          "heading": false
        },
        {
          "term": "load data",
          "heading": false
        },
        {
          "term": "load dashboard",
          "heading": false
        },
        {
          "term": "laboratory requisition",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        }
      ],
      "extract": "Fig. 3. Example of high-level standard operating procedures for data capture, ﬂow and analysis with associated monitoring and evaluation tools (in navy blue) UPDATING AND DEVELOPING MONITORING AND EVALUATION TOOLS FOR CAPTURING DATA RELATED TO VIRAL LOAD Effective tracking of viral load testing and patient outcomes requires multiple monitoring and evaluation tools and systems from multiple locations (facilities,",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-012",
        "library/10665-324745/blocks/figure-vfig-p012"
      ]
    },
    {
      "id": "page-013",
      "number": null,
      "title": "Page 13",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 13,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 613,
      "summary": {
        "text": "Sets out key variables for viral load requisition forms and other tools, and argues that a dedicated register is needed to follow people with viral load of 1000 copies/mL or more over time. It lists the variables such a high viral load register should contain.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "load register",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "therapy regimen",
          "heading": false
        },
        {
          "term": "patient identiﬁcation",
          "heading": false
        }
      ],
      "extract": "Fig. 4. Key variables to consider for laboratory requisition forms and other monitoring and editing tools forms. Some of these variables should also be integrated into other monitoring and evaluation tools such as patient cards or charts, antiretroviral therapy registers, high viral load registers and viral load sample logbooks. Note that all the variables (those entered at the clinic and at the laboratory) should",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-013",
        "library/10665-324745/blocks/figure-vfig-p013"
      ]
    },
    {
      "id": "page-014",
      "number": null,
      "title": "Page 14",
      "level": 1,
      "pageStart": 14,
      "pageEnd": 14,
      "labelStart": "12",
      "labelEnd": "12",
      "words": 806,
      "summary": {
        "text": "Discusses checking data quality by comparing site records with laboratory information systems and linking facility and laboratory systems. It stresses tracking outcomes for individuals rather than tests, and the need for site staff to follow procedures for moving results into patient records.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load tests",
          "heading": false
        },
        {
          "term": "laboratory requisition",
          "heading": false
        },
        {
          "term": "patient charts",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "patient management",
          "heading": false
        },
        {
          "term": "laboratory information",
          "heading": false
        }
      ],
      "extract": "source of patient data used for reporting is accurate. Data for sites on the numbers of individuals who received a viral load test and their results should be compared between site-level records and systems and laboratory management information systems to ensure that there are no major discrepancies. Different data sources (such as laboratory information management system, patient charts and registers) should be",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-014"
      ]
    },
    {
      "id": "page-015",
      "number": null,
      "title": "Page 15",
      "level": 1,
      "pageStart": 15,
      "pageEnd": 15,
      "labelStart": "13",
      "labelEnd": "13",
      "words": 799,
      "summary": {
        "text": "A table of common challenges in viral load monitoring and evaluation with suggested responses, such as mapping sample flows, aligning indicators with guidelines, developing standard procedures and training, and tracking unique individuals over time.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load suppression",
          "heading": false
        },
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "load tests",
          "heading": false
        },
        {
          "term": "tracking viral",
          "heading": false
        },
        {
          "term": "load coverage",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        }
      ],
      "extract": "Table 1. Summary and suggestions to address key challenges in viral load monitoring and evaluation Challenge Suggestions Using data from unlinked laboratory, facility and/ or national aggregate reporting systems • Map out the ﬂow of samples and results to and from facilities • Identify key indicators for routine monitoring that align with viral load testing guidelines, clinical algorithms and standard operating",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-015",
        "library/10665-324745/blocks/table-001"
      ]
    },
    {
      "id": "page-016",
      "number": null,
      "title": "Page 16",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 16,
      "labelStart": "14",
      "labelEnd": "14",
      "words": 483,
      "summary": {
        "text": "Lists topics that data training for staff should cover and calls for ongoing data quality assessments and mentorship, especially early in tool roll-out. It also covers training on data use at patient and programme levels and ends with summary action points.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load registers",
          "heading": false
        },
        {
          "term": "load monitoring",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "evaluation tools",
          "heading": false
        },
        {
          "term": "therapy registers",
          "heading": false
        },
        {
          "term": "patient cards",
          "heading": false
        },
        {
          "term": "evaluation systems",
          "heading": false
        }
      ],
      "extract": "procedures and reflected in the quality of data. Training should emphasize the following: • accurate and complete documentation in forms, registers and/or databases; • clarity about individual roles and responsibilities in data collection and reporting; • review of testing algorithms, standard operating procedures and processes; • correct methods to aggregate data for reporting; • consistent data capture at sites",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-016"
      ]
    },
    {
      "id": "page-017",
      "number": null,
      "title": "Page 17",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 17,
      "labelStart": "15",
      "labelEnd": "15",
      "words": 673,
      "summary": {
        "text": "Opens section 2 on indicators for viral load testing, drawn from WHO strategic information guidelines and PEPFAR MER guidance, which countries may adapt. It stresses disaggregation by age and priority populations, introduces routine monitoring of the viral load cascade, and lists example indicators up to regimen switching.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "follow-up viral",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        }
      ],
      "extract": "2. INDICATORS OF THE IMPLEMENTATION AND OUTCOMES OF VIRAL LOAD TESTING This publication compiles and presents several key viral load indicators from multiple sources, including the WHO consolidated strategic information guidelines for HIV in the health sector (1) and PEPFAR Monitoring, Evaluation and Reporting (MER) Guidance v2.0 (4). Country programmes can adapt relevant indicators appropriate to their country",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-017",
        "library/10665-324745/blocks/table-002"
      ]
    },
    {
      "id": "page-018",
      "number": null,
      "title": "Page 18",
      "level": 1,
      "pageStart": 18,
      "pageEnd": 18,
      "labelStart": "16",
      "labelEnd": "16",
      "words": 586,
      "summary": {
        "text": "Explains that core routine indicators show progress on viral load scale-up and the third 90 target, pointing to a fuller list in Annex 5. A table presents core indicators on processes, coverage, quality and patient outcomes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "routine viral",
          "heading": false
        },
        {
          "term": "load scale-up",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "cross-sectional cascade",
          "heading": false
        }
      ],
      "extract": "be measured. When reviewed together, the routine monitoring indicators should reflect how well the country is implementing viral load scale-up and progressing towards achieving the third 90 of the 90–90–90 targets. Table 2 presents a list of core indicators that are considered essential for routine viral load cascade monitoring and programme implementation, including monitoring patients with a non-suppressed viral",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-018",
        "library/10665-324745/blocks/figure-vfig-p018"
      ]
    },
    {
      "id": "page-019",
      "number": null,
      "title": "Page 19",
      "level": 1,
      "pageStart": 19,
      "pageEnd": 19,
      "labelStart": "17",
      "labelEnd": "17",
      "words": 678,
      "summary": {
        "text": "Discusses tracking viral load testing coverage and the cascade of outcomes for people with suppressed viral load, including referral to less intensive differentiated care. It explains how to calculate denominators based on those due a test under national algorithms, with figures showing cascade indicators.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "received viral",
          "heading": false
        },
        {
          "term": "receive viral",
          "heading": false
        },
        {
          "term": "routine viral",
          "heading": false
        }
      ],
      "extract": "receives routine viral load tests according to national testing guidelines, the proportion of people receiving antiretroviral therapy who have access to and receive a viral load test should be tracked to monitor viral load testing coverage and outcomes. Developing cascades with associated indicators are important to monitor viral load testing coverage and the maturation of systems and processes so that rates of",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-019",
        "library/10665-324745/blocks/figure-vfig-p019"
      ]
    },
    {
      "id": "page-020",
      "number": null,
      "title": "Page 20",
      "level": 1,
      "pageStart": 20,
      "pageEnd": 20,
      "labelStart": "18",
      "labelEnd": "18",
      "words": 530,
      "summary": {
        "text": "Covers monitoring of people whose viral load is 1000 copies/mL or more, using a high viral load register to track adherence counselling, repeat testing and regimen switching. A worked cascade example shows drop-off at each step.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "load cascade",
          "heading": false
        },
        {
          "term": "load register",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "non-suppressed viral",
          "heading": false
        },
        {
          "term": "load among",
          "heading": false
        },
        {
          "term": "follow-up viral",
          "heading": false
        }
      ],
      "extract": "MONITORING AND EVALUATION CONSIDERATIONS FOR PEOPLE WITHOUT SUPPRESSED VIRAL LOADS People without suppressed viral loads require more intensive monitoring and specific tools and systems to track interventions. Fig. 6 illustrates the cascade for people with viral load ≥1000 copies/mL. Country programmes should ensure that monitoring and evaluation tools (such as a high viral load register) are available for closely",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-020",
        "library/10665-324745/blocks/figure-vfig-p020"
      ]
    },
    {
      "id": "page-021",
      "number": null,
      "title": "Page 21",
      "level": 1,
      "pageStart": 21,
      "pageEnd": 21,
      "labelStart": "19",
      "labelEnd": "19",
      "words": 662,
      "summary": {
        "text": "Lists further monitoring questions that good data can answer, such as differences in suppression by sex, site, pregnancy status and age, and sample rejection rates. It also discusses routine data quality assessment and use of results to improve data.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral loads",
          "heading": false
        },
        {
          "term": "non-suppressed viral",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "load data",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        },
        {
          "term": "quality assessments",
          "heading": false
        },
        {
          "term": "quality protocols",
          "heading": false
        }
      ],
      "extract": "With appropriate and robust monitoring and evaluation systems and tools in place, data can be used to examine other monitoring questions related to service delivery. • What are the differences in rates of suppressed viral loads between men and women receiving antiretroviral therapy? • Which sites have especially poor rates of suppressed viral loads? • What percentage of samples collected are rejected because of",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-021"
      ]
    },
    {
      "id": "page-022",
      "number": null,
      "title": "Page 22",
      "level": 1,
      "pageStart": 22,
      "pageEnd": 22,
      "labelStart": "20",
      "labelEnd": "20",
      "words": 688,
      "summary": {
        "text": "Describes planning for data analysis and use, including disaggregating viral load outcomes by age group and priority or key populations, given higher non-suppression among children and adolescents. It also covers presenting data for review and using them for planning, programme improvement and commodity forecasting.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load suppression",
          "heading": false
        },
        {
          "term": "analysing data",
          "heading": false
        },
        {
          "term": "routine viral",
          "heading": false
        },
        {
          "term": "programme data",
          "heading": false
        },
        {
          "term": "reviewing data",
          "heading": false
        },
        {
          "term": "data analysis",
          "heading": false
        }
      ],
      "extract": "ANALYSING AND USING DATA FOR IMPROVING PROGRAMMES Developing a clear plan for analysing and using data in the early phases of scale-up can motivate staff to collect, review and analyse viral load testing data. The data analysis plan should include analysing overall viral load testing coverage and outcomes at the site and above- site levels, reviewing data by age groups and for various priority and key populations",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-022"
      ]
    },
    {
      "id": "page-023",
      "number": null,
      "title": "Page 23",
      "level": 1,
      "pageStart": 23,
      "pageEnd": 23,
      "labelStart": "21",
      "labelEnd": "21",
      "words": 621,
      "summary": {
        "text": "Opens section 3 on enhanced monitoring of viral load implementation and service quality assessment at sites against implementation standards. It also introduces planning for evaluation, including process evaluation of barriers and facilitators to testing.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "site-level compliance",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load service",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load values",
          "heading": false
        },
        {
          "term": "detectable viral",
          "heading": false
        },
        {
          "term": "load implementation",
          "heading": false
        },
        {
          "term": "evaluating viral",
          "heading": false
        }
      ],
      "extract": "Assessing service quality and evaluating viral load testing 3. ASSESSING SERVICE QUALITY AND EVALUATING VIRAL LOAD TESTING Country programmes may want to enhance the monitoring of viral load implementation, especially during scale-up, to promptly identify problems and take corrective action. Further, evaluation should be planned early to ensure that robust data are collected and reviewed to inform the implementation",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-023"
      ]
    },
    {
      "id": "page-024",
      "number": null,
      "title": "Page 24",
      "level": 1,
      "pageStart": 24,
      "pageEnd": 24,
      "labelStart": "22",
      "labelEnd": "22",
      "words": 567,
      "summary": {
        "text": "Offers sample process-evaluation questions for HIV viral load testing programmes, such as whether scale-up went as planned, whether staff were trained and supported, and how well sample transport and results return work. It closes with recommendations to define the type of evaluation early and to draft evaluation protocols in time to collect baseline data.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "outcome evaluation",
          "heading": false
        },
        {
          "term": "evaluation questions",
          "heading": false
        },
        {
          "term": "evaluation protocols",
          "heading": false
        },
        {
          "term": "evaluation plan",
          "heading": false
        },
        {
          "term": "process evaluation",
          "heading": false
        }
      ],
      "extract": "technicians and monitoring and evaluation officers) and identify lessons learned to inform further scale-up efforts. Examples of process evaluation questions • Was viral load testing scaled up and implemented as planned? Why? What worked? What did not work? • How are monitoring and evaluation, programme or clinical and laboratory staff working together to review and use data on the performance of viral load testing?",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-024"
      ]
    },
    {
      "id": "page-025",
      "number": null,
      "title": "Page 25",
      "level": 1,
      "pageStart": 25,
      "pageEnd": 25,
      "labelStart": "23",
      "labelEnd": "23",
      "words": 123,
      "summary": {
        "text": "A list of references for the viral load monitoring guidance, citing mainly WHO HIV strategic information and patient monitoring guidelines, a PEPFAR indicator guide and a meta-analysis on viral suppression in children.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "accessed march",
          "heading": false
        },
        {
          "term": "bitstream eng",
          "heading": false
        },
        {
          "term": "pepfar",
          "heading": false
        },
        {
          "term": "world health",
          "heading": false
        },
        {
          "term": "wit",
          "heading": false
        }
      ],
      "extract": "REFERENCES 1. Consolidated strategic information guidelines for HIV in the health sector. Geneva: World Health Organization; 2015 (http://apps.who.int/iris/ bitstream/10665/164716/1/9789241508759_eng. pdf?ua=1&ua=1, accessed 25 March 2019). 2. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. Geneva: World Health Organization; 2017 (http://www.who.int/hiv/pub/",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-025"
      ]
    },
    {
      "id": "page-026",
      "number": null,
      "title": "Page 26",
      "level": 1,
      "pageStart": 26,
      "pageEnd": 26,
      "labelStart": "24",
      "labelEnd": "24",
      "words": 606,
      "summary": {
        "text": "Annex 1 sets out a logic model for routine HIV viral load testing, running from inputs such as funding, staff, policies and equipment through planning and implementation activities to outputs and outcomes. Planning activities include assessing laboratory and transport capacity, choosing sample types and platforms, writing clinical algorithms, updating tools and training plans, and drafting a costed, phased plan, while expected long-term results include fewer AIDS-related deaths and new HIV infections.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "monitoring viral",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "routine viral",
          "heading": false
        },
        {
          "term": "therapy increased",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        },
        {
          "term": "outcomes increased",
          "heading": false
        }
      ],
      "extract": "ANNEX 1. LOGIC MODEL FOR ROUTINE VIRAL LOAD TESTING OUTPUTS ACTIVITIES OUTPUTS OUTCOMES • Funding • Staff such as laboratory technicians, transport network and clinic staff • Policies • Partnerships • Equipment, supplies, reagents etc. Laboratory and specimen transport network PLANNING • Assess the capacity of staff, the existing specimen transport network, infrastructure, molecular laboratories, testing modalities,",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-026"
      ]
    },
    {
      "id": "page-027",
      "number": null,
      "title": "Page 27",
      "level": 1,
      "pageStart": 27,
      "pageEnd": 27,
      "labelStart": "25",
      "labelEnd": "25",
      "words": 109,
      "summary": {
        "text": "Introduces Annex 2, a tool for assessing whether monitoring and evaluation systems can routinely track viral load testing, and explains that it can be used throughout implementation, ideally within a wider review of the M&E system.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "evaluation systems",
          "heading": false
        },
        {
          "term": "tool",
          "heading": false
        }
      ],
      "extract": "ANNEX 2. TOOL AND CHECKLIST FOR ASSESSING MONITORING AND EVALUATION SYSTEMS FOR VIRAL LOAD TESTING Purpose: The purpose of this tool is to guide the assessment of monitoring and evaluation systems and their capacity to routinely monitor and track viral load testing. The process of collecting data by using monitoring and evaluation tools should be well aligned with the goal of informing and improving programme",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-027"
      ]
    },
    {
      "id": "page-028",
      "number": null,
      "title": "Page 28",
      "level": 1,
      "pageStart": 28,
      "pageEnd": 28,
      "labelStart": "26",
      "labelEnd": "26",
      "words": 501,
      "summary": {
        "text": "Continues the M&E assessment checklist with questions on mapping sample and data flows between sites and laboratories and on whether patient cards and antiretroviral therapy registers have fields for viral load testing. It also asks whether systems can follow cohorts' viral load results over time, with space to record findings and recommendations.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "data ﬂow",
          "heading": false
        },
        {
          "term": "sample ﬂow",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "ﬁelds",
          "heading": false
        },
        {
          "term": "laboratory electronic",
          "heading": false
        },
        {
          "term": "capture data",
          "heading": false
        }
      ],
      "extract": "Area of system to review Assessment questions Findings Recommendation Data ﬂow and data capture • Has the sample ﬂow from the site to the laboratory been clearly mapped? • Has the data ﬂow from the site to laboratory and back to the site (such as returning results) been clearly mapped? • Have data capture forms been mapped to data and sample ﬂow? Is it clear what form will be used at which point in sample transport",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-028"
      ]
    },
    {
      "id": "page-029",
      "number": null,
      "title": "Page 29",
      "level": 1,
      "pageStart": 29,
      "pageEnd": 29,
      "labelStart": "27",
      "labelEnd": "27",
      "words": 383,
      "summary": {
        "text": "Continues the assessment checklist with questions on data reporting, such as whether paper and electronic reporting forms include viral load indicators and can track both tests and individuals. It also covers data analysis and use, including updated M&E plans, 90–90–90 indicators, disaggregation and follow-up of data quality findings.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "required ﬁelds",
          "heading": false
        },
        {
          "term": "data quality",
          "heading": false
        },
        {
          "term": "data reporting",
          "heading": false
        },
        {
          "term": "reporting systems",
          "heading": false
        },
        {
          "term": "review data",
          "heading": false
        },
        {
          "term": "service quality",
          "heading": false
        }
      ],
      "extract": "Area of system to review Assessment questions Findings Recommendation Data reporting • Have routine data reporting forms been updated to include the required ﬁelds for key viral load testing indicators? • Have electronic reporting systems been updated to integrate the required ﬁelds for reporting and monitoring viral load testing and results? • Can the programme report on tests and/or individuals? Can the programme",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-029"
      ]
    },
    {
      "id": "page-030",
      "number": null,
      "title": "Page 30",
      "level": 1,
      "pageStart": 30,
      "pageEnd": 30,
      "labelStart": "28",
      "labelEnd": "28",
      "words": 132,
      "summary": {
        "text": "Ends the assessment checklist with questions on capacity, including training plans for staff on completing tools, ongoing mentorship, follow-up of data quality reviews and a forum for sharing lessons on viral load monitoring.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "mentorship",
          "heading": false
        },
        {
          "term": "on-site",
          "heading": false
        }
      ],
      "extract": "Area of system to review Assessment questions Findings Recommendation Capacity • Is a plan being developed to train service providers, laboratory staff, monitoring and evaluation staff and others on the correct completion of tools? Does this training also incorporate elements of the clinical cascade to clearly show how the data relate to the three 90–90–90 targets? • Is there a plan and schedule to provide ongoing",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-030"
      ]
    },
    {
      "id": "page-031",
      "number": null,
      "title": "Page 31",
      "level": 1,
      "pageStart": 31,
      "pageEnd": 31,
      "labelStart": "29",
      "labelEnd": "29",
      "words": 539,
      "summary": {
        "text": "Annex 3 begins with example M&E tools for viral load monitoring, starting with Uganda's Ministry of Health laboratory request form for HIV viral load analysis. The form captures facility, patient, treatment and sample details, with the reverse side used to send results back to the facility.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "yyyy",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "code above",
          "heading": false
        },
        {
          "term": "dar",
          "heading": false
        },
        {
          "term": "request form",
          "heading": false
        },
        {
          "term": "lab request",
          "heading": false
        },
        {
          "term": "yrs",
          "heading": false
        },
        {
          "term": "line children",
          "heading": false
        }
      ],
      "extract": "ANNEX 3. EXAMPLES OF KEY MONITORING AND EVALUATION TOOLS FOR VIRAL LOAD MONITORING Laboratory requisition form and viral load results form. An example from from the Government of Uganda: lab request form. The front side is the lab request form that accompanies the viral load sample from the facility to the laboratory hub and the centralized laboratory for testing and processing. The back side is the viral load",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-031"
      ]
    },
    {
      "id": "page-032",
      "number": null,
      "title": "Page 32",
      "level": 1,
      "pageStart": 32,
      "pageEnd": 32,
      "labelStart": "30",
      "labelEnd": "30",
      "words": 166,
      "summary": {
        "text": "Reproduces the results side of Uganda's central public health laboratory viral load form, with fields for sample, patient and test details and suggested clinical actions such as adherence counselling and repeat testing for unsuppressed results.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "date",
          "heading": false
        },
        {
          "term": "sample",
          "heading": false
        },
        {
          "term": "test",
          "heading": false
        },
        {
          "term": "lab",
          "heading": false
        },
        {
          "term": "yes",
          "heading": false
        }
      ],
      "extract": "\"a SANAS Accredited Medical Laboratory, No. M0589\" 1 of 1 MINISTRY OF HEALTH UGANDA CENTRAL PUBLIC HEALTH LABORATORIES TREATMENT INFORMATION VIRAL LOAD RESULTS RECOMMENDATIONS FACILITY DETAILS Name: _______________________ District: O +XE\u001d SAMPLE DETAILS Form #: ______ Sample Type: DBS Plasma PATIENT INFORMATION ART Number: _______ Other ID: ________ Sex: Female Male Left Blank Date of Birth: _____________ Phone",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-032",
        "library/10665-324745/blocks/figure-img-p032-128",
        "library/10665-324745/blocks/figure-img-p032-129"
      ]
    },
    {
      "id": "page-033",
      "number": null,
      "title": "Page 33",
      "level": 1,
      "pageStart": 33,
      "pageEnd": 33,
      "labelStart": "31",
      "labelEnd": "31",
      "words": 1268,
      "summary": {
        "text": "Shows an example antiretroviral therapy register from Uganda that includes fields for recording viral load results so that cohorts on treatment can be tracked over time. The text notes that results are expected at six and 12 months after starting treatment and yearly afterwards, and that the register is split across two tables to fit the page. Most of the block is the register's column headings for patient details, regimens, CD4 counts and viral load by month.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "nutrition status",
          "heading": false
        },
        {
          "term": "adh",
          "heading": false
        },
        {
          "term": "reason date",
          "heading": false
        },
        {
          "term": "cpt",
          "heading": false
        },
        {
          "term": "stop date",
          "heading": false
        },
        {
          "term": "arvs",
          "heading": false
        },
        {
          "term": "start date",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        }
      ],
      "extract": "Antiretroviral therapy register with ﬁelds for recording viral load results. Example from the Government of Uganda: an antiretroviral therapy register that can track cohorts of people receiving antiretroviral therapy. This shows an example of a field to document viral load test results. In accordance with the guidelines, a viral load test result is expected to be documented at six months after antiretroviral therapy",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-033"
      ]
    },
    {
      "id": "page-034",
      "number": null,
      "title": "Page 34",
      "level": 1,
      "pageStart": 34,
      "pageEnd": 34,
      "labelStart": "32",
      "labelEnd": "32",
      "words": 416,
      "summary": {
        "text": "Presents an optional form for recording follow-up of people with a viral load of 1000 copies/mL or more, covering patient and regimen details, enhanced adherence counselling sessions, repeat test results and regimen switching. Parts of the extracted form text are garbled, with missing or substituted letters.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "adherence counsellor",
          "heading": false
        },
        {
          "term": "adherence counselling",
          "heading": false
        },
        {
          "term": "enhanced adherence",
          "heading": false
        },
        {
          "term": "yyyy",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "therapy regimen",
          "heading": false
        },
        {
          "term": "pill",
          "heading": false
        }
      ],
      "extract": "High viral load results form. This is an optional form to record follow-up actions for people with viral load ≥1000 copies/mL. This would be maintained in the patient chart or incorporated into electronic medical record systems but can also be used to complete the high viral load register or logbook (see the next tool example). Key fields include: patient contact information, antiretroviral therapy regimen",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-034"
      ]
    },
    {
      "id": "page-035",
      "number": null,
      "title": "Page 35",
      "level": 1,
      "pageStart": 35,
      "pageEnd": 35,
      "labelStart": "33",
      "labelEnd": "33",
      "words": 209,
      "summary": {
        "text": "Continues the high viral load form with sections for the first to third enhanced adherence counselling sessions, recording adherence, pill counts, barriers and agreed action plans; some of the extracted text is garbled.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "eac session",
          "heading": false
        },
        {
          "term": "pill intake",
          "heading": false
        },
        {
          "term": "agreed lan",
          "heading": false
        },
        {
          "term": "pill count",
          "heading": false
        },
        {
          "term": "adherence barrier",
          "heading": false
        },
        {
          "term": "identified adherence",
          "heading": false
        }
      ],
      "extract": "1st EAC session Identified adherence barrier\u0006s Agreed -lan of action A\u0019\u001c\u0004inta(e demonstration by -atient\u0006careta(er done ☐ \u001d ☐ \u0016 Counsellor: __________________________________ Date (DD/MM/YYYY): ____/____/________ nd EAC session Counsellor: __________________________________ Date (DD/MM/YYYY): ____/____/________ Adherence since last session (e.g, over last month) \u0000 Good \u0000 Fair \u0000 Poor Pill count done? Y ☐ N ☐ Pill",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-035"
      ]
    },
    {
      "id": "page-036",
      "number": null,
      "title": "Page 36",
      "level": 1,
      "pageStart": 36,
      "pageEnd": 36,
      "labelStart": "34",
      "labelEnd": "34",
      "words": 189,
      "summary": {
        "text": "Completes the high viral load form with spaces for additional counselling sessions, the repeat viral load result and the plan for patients whose viral load stays high, with provider sign-off; parts of the extracted text are garbled.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pill intake",
          "heading": false
        },
        {
          "term": "eac session",
          "heading": false
        },
        {
          "term": "pill count",
          "heading": false
        },
        {
          "term": "adherence barrier",
          "heading": false
        },
        {
          "term": "agreed lan",
          "heading": false
        },
        {
          "term": "yyyy",
          "heading": false
        }
      ],
      "extract": "Additional EAC session Counsellor: __________________________________ Date (DD/MM/YYYY): ____/____/________ Adherence since last session (e.g, over last month) \u0000 Good \u0000 Fair \u0000 Poor Pill count done? Y ☐ N ☐ Pill intake: ___% Identified adherence barrier\u0006s Agreed -lan of action Additional EAC session Counsellor: __________________________________ Date (DD/MM/YYYY): ____/____/________ Adherence since last session (e.g,",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-036"
      ]
    },
    {
      "id": "page-037",
      "number": null,
      "title": "Page 37",
      "level": 1,
      "pageStart": 37,
      "pageEnd": 37,
      "labelStart": "35",
      "labelEnd": "35",
      "words": 268,
      "summary": {
        "text": "Shows an example longitudinal register for tracking patients with a viral load of 1000 copies/mL or more through enhanced adherence counselling, repeat testing and outcomes such as staying on or switching regimen. The register's column headings are listed across two tables, and programmes are invited to adapt it.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "eac session",
          "heading": false
        },
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "date",
          "heading": false
        },
        {
          "term": "table corresponds",
          "heading": false
        },
        {
          "term": "register",
          "heading": false
        },
        {
          "term": "switched",
          "heading": false
        }
      ],
      "extract": "High viral load results follow-up register. Examples of a longitudinal register to track patients with viral load ≥1000 copies/mL. Country programmes can adapt the register for their settings. Sites should complete these registers for all patients with an initial viral load ≥1000 copies/mL to track enhanced adherence counselling, follow-up viral load test, result, outcome (such as maintained on regimen or switched)",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-037"
      ]
    },
    {
      "id": "page-038",
      "number": null,
      "title": "Page 38",
      "level": 1,
      "pageStart": 38,
      "pageEnd": 38,
      "labelStart": "36",
      "labelEnd": "36",
      "words": 380,
      "summary": {
        "text": "Annex 4 gives a template for a national monitoring and evaluation plan for viral load testing, listing the key sections for programme monitoring and for evaluation. It recommends developing separate performance monitoring and evaluation plans and begins with guidance on describing stakeholders, indicators, and data systems and management.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "evaluation plan",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "monitoring plan",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "performance monitoring",
          "heading": false
        },
        {
          "term": "laboratory staff",
          "heading": false
        },
        {
          "term": "monitoring question",
          "heading": false
        }
      ],
      "extract": "ANNEX 4. EXAMPLE OF A TEMPLATE FOR A NATIONAL MONITORING AND EVALUATION PLAN FOR VIRAL LOAD TESTING The following key sections should be included in a national monitoring and evaluation plan for viral load testing. Programme monitoring • Main stakeholders • Indicators that include definitions, disaggregation, data sources and frequency of reporting – Baseline data and targets to be achieved with time frame –",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-038"
      ]
    },
    {
      "id": "page-039",
      "number": null,
      "title": "Page 39",
      "level": 1,
      "pageStart": 39,
      "pageEnd": 39,
      "labelStart": "37",
      "labelEnd": "37",
      "words": 421,
      "summary": {
        "text": "Continues the national M&E plan template with guidance on describing data analysis and quality assurance, how data will be used and shared, and the planned evaluation's purpose, questions, team, timeline and budget. It ends with sources on programme evaluation from CDC and PEPFAR.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "evaluation ﬁndings",
          "heading": false
        },
        {
          "term": "evaluation plan",
          "heading": false
        },
        {
          "term": "evaluation team",
          "heading": false
        },
        {
          "term": "logic model",
          "heading": false
        },
        {
          "term": "data quality",
          "heading": false
        },
        {
          "term": "attach",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "programme goals",
          "heading": false
        }
      ],
      "extract": "Data analysis and quality Briefly describe the data analysis and data quality assurance plans for viral load data. For example, specify how data will be analysed at the site, district and national levels and by subpopulations (such as pregnant women, breastfeeding women and age and sex disaggregation). Data quality assurance plans can include description of checks to compare data between unlinked systems (such as a",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-039"
      ]
    },
    {
      "id": "page-040",
      "number": null,
      "title": "Page 40",
      "level": 1,
      "pageStart": 40,
      "pageEnd": 40,
      "labelStart": "38",
      "labelEnd": "38",
      "words": 142,
      "summary": {
        "text": "Introduces Annex 5, a set of core indicators for scaling up viral load testing, stressing that programmes should pick and adapt relevant indicators rather than track all of them, and noting the PEPFAR and WHO sources used.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "indicators",
          "heading": false
        },
        {
          "term": "mer",
          "heading": false
        },
        {
          "term": "edit",
          "heading": false
        },
        {
          "term": "went",
          "heading": false
        }
      ],
      "extract": "ANNEX 5. CORE PROGRAMME INDICATORS FOR SCALING UP AND IMPLEMENTING VIRAL LOAD TESTING Country programmes should select relevant and helpful indicators for their programmes from Annex 5 (in addition to their own indicators, as applicable); programmes are not required or expected to monitor all indicators below. Further, programmes should edit or adapt indicators suggested by this framework for their settings. Please",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-040"
      ]
    },
    {
      "id": "page-041",
      "number": null,
      "title": "Page 41",
      "level": 1,
      "pageStart": 41,
      "pageEnd": 41,
      "labelStart": "39",
      "labelEnd": "39",
      "words": 438,
      "summary": {
        "text": "Sets out system and process indicators for viral load testing, beginning with the share of viral load samples that antiretroviral therapy sites send to the laboratory or transport network. Each indicator gives its numerator, denominator, disaggregations, data sources and why it matters to the programme.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load samples",
          "heading": false
        },
        {
          "term": "load tests",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "unique viral",
          "heading": false
        },
        {
          "term": "samples submitted",
          "heading": false
        },
        {
          "term": "therapy sites",
          "heading": false
        },
        {
          "term": "samples received",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What is the access and coverage of viral load samples submitted by antiretrovir al therapy sites to the laboratory or specimen? Percentage of unique viral load tests submitted by sites to the laboratory or specimen transport Numerator: number of unique",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-041"
      ]
    },
    {
      "id": "page-042",
      "number": null,
      "title": "Page 42",
      "level": 1,
      "pageStart": 42,
      "pageEnd": 42,
      "labelStart": "40",
      "labelEnd": "40",
      "words": 409,
      "summary": {
        "text": "Continues the system and process indicators, covering items such as the proportion of samples each laboratory rejects and the reasons why. It also notes the importance of recording how long viral load instruments are out of service and why.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load sample",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "spot plasma",
          "heading": false
        },
        {
          "term": "dried blood",
          "heading": false
        },
        {
          "term": "rejected",
          "heading": false
        },
        {
          "term": "site name",
          "heading": false
        },
        {
          "term": "subnational unit",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What proportion of viral load samples is rejected for processing by each laboratory or hub? Percentage of viral load tests rejected by each laboratory Numerator: number of viral load samples rejected at each laboratory Denominator: number of viral load",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-042"
      ]
    },
    {
      "id": "page-043",
      "number": null,
      "title": "Page 43",
      "level": 1,
      "pageStart": 43,
      "pageEnd": 43,
      "labelStart": "41",
      "labelEnd": "41",
      "words": 556,
      "summary": {
        "text": "Continues the system and process indicators with measures of whether returned viral load results are recorded in patient charts and registers. It notes that gaps can be explored through data quality assessments and supportive supervision visits.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "load standard",
          "heading": false
        },
        {
          "term": "load algorithms",
          "heading": false
        },
        {
          "term": "load tests",
          "heading": false
        },
        {
          "term": "performing viral",
          "heading": false
        },
        {
          "term": "operating procedures",
          "heading": false
        },
        {
          "term": "staff dedicated",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What proportion of viral load test results returned to antiretroviral therapy sites were recorded in patient charts and/or antiretroviral therapy registers? Percentage of people living with HIV receiving antiretroviral therapy with a viral load result",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-043"
      ]
    },
    {
      "id": "page-044",
      "number": null,
      "title": "Page 44",
      "level": 1,
      "pageStart": 44,
      "pageEnd": 44,
      "labelStart": "42",
      "labelEnd": "42",
      "words": 574,
      "summary": {
        "text": "Starts the health outcome indicators for viral load scale-up, such as the share of people on antiretroviral therapy who had a viral load test at six months and who were virally suppressed. Each indicator lists its definition, disaggregation, data sources, relevance and the WHO or PEPFAR guidance it comes from.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "initiating antiretroviral",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        },
        {
          "term": "load suppression",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What proportion of people receiving antiretroviral therapy received a viral load test at six months after initiating antiretroviral therapy and had suppressed viral loads? Percentage of people receiving antiretroviral therapy who had viral load monitored",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-044"
      ]
    },
    {
      "id": "page-045",
      "number": null,
      "title": "Page 45",
      "level": 1,
      "pageStart": 45,
      "pageEnd": 45,
      "labelStart": "43",
      "labelEnd": "43",
      "words": 618,
      "summary": {
        "text": "Continues the health outcome indicators with measures of viral load testing coverage in the past 12 months and of viral suppression among people on treatment. It gives numerators, denominators, disaggregations, data sources and the PEPFAR or WHO source for each.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "load testing",
          "heading": false
        },
        {
          "term": "laboratory records",
          "heading": false
        },
        {
          "term": "medical records",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What is the coverage of viral load testing? Percentage of people receiving antiretroviral therapy receiving a viral load test in the past 12 months Numerator: number of people living with HIV receiving antiretroviral therapy with at least one viral load",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-045"
      ]
    },
    {
      "id": "page-046",
      "number": null,
      "title": "Page 46",
      "level": 1,
      "pageStart": 46,
      "pageEnd": 46,
      "labelStart": "44",
      "labelEnd": "44",
      "words": 575,
      "summary": {
        "text": "Continues the outcome indicators with measures such as the share of virally suppressed people referred to less intensive, differentiated models of care. It also covers indicators for people with non-suppressed viral loads, noting that programmes should adapt them to their enhanced adherence counselling guidelines.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "enhanced adherence",
          "heading": false
        },
        {
          "term": "counselling enhanced",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "received enhanced",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What proportion of people living with HIV with suppressed viral loads (<1000 copies/ml) have been referred to a less intensive model of care or differentiated service delivery in the past 12 months? Percentage of people living with HIV with suppressed",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-046"
      ]
    },
    {
      "id": "page-047",
      "number": null,
      "title": "Page 47",
      "level": 1,
      "pageStart": 47,
      "pageEnd": 47,
      "labelStart": "45",
      "labelEnd": "45",
      "words": 673,
      "summary": {
        "text": "Continues the outcome indicators with the proportion of people with a viral load of 1000 copies/mL or more who had a follow-up test within six months of enhanced adherence counselling. It explains that such indicators help show the impact of interventions and inform estimates of HIV drug resistance.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "load copies",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "load test",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "follow-up viral",
          "heading": false
        },
        {
          "term": "counselling enhanced",
          "heading": false
        },
        {
          "term": "enhanced adherence",
          "heading": false
        },
        {
          "term": "antiretroviral therapy",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What proportion of people receiving antiretroviral therapy with a viral load ≥1000 copies/ mL received a follow-up viral load test within six months? Percentage of people receiving antiretroviral therapy with viral load ≥1000 copies/ mL who received a",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-047",
        "library/10665-324745/blocks/figure-vfig-p047"
      ]
    },
    {
      "id": "page-048",
      "number": null,
      "title": "Page 48",
      "level": 1,
      "pageStart": 48,
      "pageEnd": 48,
      "labelStart": "46",
      "labelEnd": "46",
      "words": 456,
      "summary": {
        "text": "Ends the outcome indicators with the share of people with two consecutive high viral load results who switch to second- or third-line antiretroviral regimens. It closes with references to WHO and PEPFAR guidance.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "antiretroviral therapy",
          "heading": false
        },
        {
          "term": "viral load",
          "heading": false
        },
        {
          "term": "third-line antiretroviral",
          "heading": false
        },
        {
          "term": "receiving antiretroviral",
          "heading": false
        },
        {
          "term": "suppressed viral",
          "heading": false
        },
        {
          "term": "therapy regimens",
          "heading": false
        },
        {
          "term": "consecutive viral",
          "heading": false
        },
        {
          "term": "programme-based denominator",
          "heading": false
        }
      ],
      "extract": "Monitoring question Indicator Numerator and denominator Disaggregation Data sources and considerations Programme relevance and importance Indicator guidance source What proportion of people receiving antiretroviral therapy with repeat viral load ≥1000 copies/ ml switch to second- or third- line antiretroviral therapy regimens? Percentage of people living with HIV receiving antiretroviral therapy with two documented",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-048"
      ]
    },
    {
      "id": "page-049",
      "number": null,
      "title": "Page 49",
      "level": 1,
      "pageStart": 49,
      "pageEnd": 49,
      "labelStart": "47",
      "labelEnd": "47",
      "words": 97,
      "summary": {
        "text": "Annex 6 lists the eleven PEPFAR evaluation standards of practice, from engaging stakeholders and stating clear questions to producing quality reports and using findings to improve programmes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pepfar evaluation",
          "heading": false
        },
        {
          "term": "evaluation standards",
          "heading": false
        },
        {
          "term": "assurances",
          "heading": false
        },
        {
          "term": "evaluator",
          "heading": false
        }
      ],
      "extract": "ANNEX 6. PEPFAR EVALUATION STANDARDS OF PRACTICE 1. Engage stakeholders 2. Clearly state evaluation questions, purpose and objectives 3. Use appropriate evaluation design, methods and analytical techniques 4. Address ethical considerations and assurances 5. Identify resources and articulate a budget 6. Construct data collection and management plans 7. Ensure appropriate evaluator qualifications and evaluation",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-049"
      ]
    },
    {
      "id": "page-050",
      "number": null,
      "title": "Page 50",
      "level": 1,
      "pageStart": 50,
      "pageEnd": 50,
      "labelStart": "48",
      "labelEnd": "48",
      "words": 544,
      "summary": {
        "text": "Annex 7 compares types of evaluation and operations research in a table describing each type, sample questions and how results are used. It begins with process evaluation, which looks at whether a programme reaches its target populations and is carried out as planned, and ends with sources including a CDC presentation on economic evaluation.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "allocation programme",
          "heading": false
        },
        {
          "term": "counterfactual scenario",
          "heading": false
        },
        {
          "term": "resource allocation",
          "heading": false
        },
        {
          "term": "inform programme",
          "heading": false
        },
        {
          "term": "programme improvement",
          "heading": false
        },
        {
          "term": "decision-making resource",
          "heading": false
        },
        {
          "term": "programme effectiveness",
          "heading": false
        },
        {
          "term": "target populations",
          "heading": false
        }
      ],
      "extract": "ANNEX 7. DIFFERENCES BETWEEN TYPES OF EVALUATION AND OPERATIONS RESEARCHa Type Description Examples of questions Use of results Process evaluation Determines whether the programme is reaching the right target populations, how a programme is being implemented and what factors help or hinder programme implementation to inform programme planning and development and take corrective action • Were target populations",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-050"
      ]
    },
    {
      "id": "page-051",
      "number": null,
      "title": "Page 51",
      "level": 1,
      "pageStart": 51,
      "pageEnd": 51,
      "labelStart": "49",
      "labelEnd": "49",
      "words": 196,
      "summary": {
        "text": "Concludes the comparison table with operations research, described as problem-focused, demand-driven research to solve practical issues in health programmes and service delivery, with example questions and sources.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "operations research",
          "heading": false
        },
        {
          "term": "problem solving",
          "heading": false
        },
        {
          "term": "speciﬁc",
          "heading": false
        },
        {
          "term": "service delivery",
          "heading": false
        },
        {
          "term": "solutions",
          "heading": false
        },
        {
          "term": "operational",
          "heading": false
        },
        {
          "term": "focus",
          "heading": false
        }
      ],
      "extract": "Type Description Examples of questions Use of results Operations research Operations research aims to develop solutions to current operational problems of speciﬁc health programmes or speciﬁc service delivery components of the health system, such as a health district or a hospital. This research is characterized by a strong problem- solving focus and an urgency to ﬁnd solutions. Its demand-driven nature and close",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-051"
      ]
    },
    {
      "id": "page-052",
      "number": null,
      "title": "Page 52",
      "level": 1,
      "pageStart": 52,
      "pageEnd": 52,
      "labelStart": "50",
      "labelEnd": "50",
      "words": 3639,
      "summary": {
        "text": "A blank page for notes.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-052"
      ]
    },
    {
      "id": "page-053",
      "number": null,
      "title": "Page 53",
      "level": 1,
      "pageStart": 53,
      "pageEnd": 53,
      "labelStart": "51",
      "labelEnd": "51",
      "words": 3639,
      "summary": {
        "text": "A blank page for notes.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-053"
      ]
    },
    {
      "id": "page-054",
      "number": null,
      "title": "Page 54",
      "level": 1,
      "pageStart": 54,
      "pageEnd": 54,
      "labelStart": "52",
      "labelEnd": "52",
      "words": 3639,
      "summary": {
        "text": "A blank notes page made up of the heading \"Notes\" and dotted lines for writing; the large word count reflects the dot leaders, not content.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .",
      "extractCut": true,
      "blocks": [
        "library/10665-324745/blocks/prose-page-054"
      ]
    },
    {
      "id": "page-055",
      "number": null,
      "title": "Page 55",
      "level": 1,
      "pageStart": 55,
      "pageEnd": 55,
      "labelStart": "53",
      "labelEnd": "53",
      "words": 5,
      "summary": {
        "text": "A blank page with no extractable text.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "_(no text on this page)_",
      "extractCut": false,
      "blocks": [
        "library/10665-324745/blocks/prose-page-055"
      ]
    },
    {
      "id": "page-056",
      "number": null,
      "title": "Page 56",
      "level": 1,
      "pageStart": 56,
      "pageEnd": 56,
      "labelStart": "54",
      "labelEnd": "54",
      "words": 20,
      "summary": {
        "text": "The back-cover contact block giving the address, e-mail and website of the WHO Department of HIV/AIDS in Geneva.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "For more information, contact: World Health Organization Department of HIV/AIDS 20, avenue Appia 1211 Geneva 27 Switzerland E-mail: hiv-aids@who.int www.who.int/hiv",
      "extractCut": false,
      "blocks": [
        "library/10665-324745/blocks/prose-page-056"
      ]
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 1,
        "items": [
          "Indicators for scale-up or viral load testing and programme outcomes"
        ]
      },
      "found_not_listed": {
        "count": 4,
        "items": [
          "2 INDICATORS OF THE IMPLEMENTATION AND OUTCOMES OF VIRAL LOAD TESTING",
          "3 ASSESSING SERVICE QUALITY AND EVALUATING VIRAL LOAD TESTING",
          "1 PERFORMANCE MONITORING PLAN",
          "2 EVALUATION PLAN"
        ]
      },
      "page_mismatch": {
        "count": 1,
        "items": [
          "implementation: listed p37, found p50"
        ]
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "viral load",
      "heading": true
    },
    {
      "term": "load monitoring",
      "heading": true
    },
    {
      "term": "load testing",
      "heading": true
    },
    {
      "term": "load data",
      "heading": true
    },
    {
      "term": "load laboratory",
      "heading": false
    },
    {
      "term": "load copies",
      "heading": false
    },
    {
      "term": "load test",
      "heading": true
    },
    {
      "term": "load registers",
      "heading": false
    },
    {
      "term": "load cascade",
      "heading": true
    },
    {
      "term": "receiving viral",
      "heading": false
    },
    {
      "term": "suppressed viral",
      "heading": false
    },
    {
      "term": "load sample",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "55",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "b",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "1",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "2",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 5,
      "label": "3",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 6,
      "label": "4",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 7,
      "label": "5",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 8,
      "label": "6",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 9,
      "label": "7",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 10,
      "label": "8",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 11,
      "label": "9",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "10",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 13,
      "label": "11",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 14,
      "label": "12",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 15,
      "label": "13",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 16,
      "label": "14",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 17,
      "label": "15",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 18,
      "label": "16",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 19,
      "label": "17",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 20,
      "label": "18",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 21,
      "label": "19",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 22,
      "label": "20",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 23,
      "label": "21",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 24,
      "label": "22",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 25,
      "label": "23",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 26,
      "label": "24",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 27,
      "label": "25",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 28,
      "label": "26",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 29,
      "label": "27",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 30,
      "label": "28",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 31,
      "label": "29",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 32,
      "label": "30",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 33,
      "label": "31",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 34,
      "label": "32",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 35,
      "label": "33",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 36,
      "label": "34",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 37,
      "label": "35",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 38,
      "label": "36",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 39,
      "label": "37",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 40,
      "label": "38",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 41,
      "label": "39",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 42,
      "label": "40",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 43,
      "label": "41",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 44,
      "label": "42",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 45,
      "label": "43",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 46,
      "label": "44",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 47,
      "label": "45",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 48,
      "label": "46",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 49,
      "label": "47",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 50,
      "label": "48",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 51,
      "label": "49",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 52,
      "label": "50",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 53,
      "label": "51",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 54,
      "label": "52",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 55,
      "label": "53",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 56,
      "label": "54",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [
    {
      "kind": "figure",
      "number": "1",
      "title": "Global indicators for the monitoring and evaluation of the health sector response",
      "page": 8,
      "pageLabel": "6",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "2",
      "title": "Example of a map of a sample transport network and the return of results for",
      "page": 11,
      "pageLabel": "9",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "3",
      "title": "Example of high-level standard operating procedures for data capture, ﬂow and",
      "page": 12,
      "pageLabel": "10",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "4",
      "title": "Key variables to consider for laboratory requisition forms and other monitoring",
      "page": 13,
      "pageLabel": "11",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "table",
      "number": "1",
      "title": "Summary and suggestions to address key challenges in viral load monitoring",
      "page": 15,
      "pageLabel": "13",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    },
    {
      "kind": "table",
      "number": "2",
      "title": "Core indicators along the viral load testing cascade",
      "page": 17,
      "pageLabel": "15",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    },
    {
      "kind": "figure",
      "number": "5",
      "title": "Cascade of routine viral load testing and key indicators to track people with",
      "page": 18,
      "pageLabel": "16",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "6",
      "title": "Viral load cascade for people with a non-suppressed viral load test result",
      "page": 19,
      "pageLabel": "17",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "7",
      "title": "Example of using routinely collected data to understand the leaks in the viral load",
      "page": 20,
      "pageLabel": "18",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    }
  ],
  "images": [
    {
      "id": "img-p001-1",
      "file": "images/img-p001-1.webp",
      "page": 1,
      "narratives": {
        "en": "Cover photograph: gloved hands hold a person's fingertip and collect a drop of blood into a thin capillary tube, next to a box of testing supplies.",
        "ar": "صورة الغلاف: أيدٍ ترتدي قفازات تمسك بطرف إصبع شخص وتجمع قطرة دم في أنبوب شعري رفيع، بجوار علبة من مستلزمات الفحص.",
        "zh": "封面照片：戴手套的双手握住一个人的指尖，用细毛细管采集一滴血液，旁边是一盒检测用品。",
        "es": "Fotografía de portada: unas manos enguantadas sujetan la yema del dedo de una persona y recogen una gota de sangre en un fino tubo capilar, junto a una caja de material para pruebas.",
        "fr": "Photo de couverture : des mains gantées tiennent le bout du doigt d’une personne et recueillent une goutte de sang dans un fin tube capillaire, à côté d’une boîte de matériel de dépistage.",
        "ru": "Фотография на обложке: руки в перчатках держат кончик пальца человека и набирают каплю крови в тонкую капиллярную трубку рядом с коробкой расходных материалов для тестирования."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p008",
      "file": "figures/vfig-p008.webp",
      "page": 8,
      "shows": [
        "Figure 1"
      ],
      "narratives": {
        "en": "Framework diagram of the health sector response to HIV, running from \"Know your epidemic\" and \"Inputs\" through \"Outputs and outcomes\" (the HIV care cascade: prevention, HIV testing service, HIV care, antiretroviral therapy, viral suppression) to \"Evaluate impact\". Below it the ten global indicators are listed, from people living with HIV and domestic funding through knowing HIV status, antiretroviral therapy and viral suppression to AIDS-related deaths and new HIV infections, with three \"90\" markers under knowing status, receiving antiretroviral therapy and viral suppression.",
        "ar": "مخطط إطاري لاستجابة القطاع الصحي لفيروس العوز المناعي البشري، يمتد من \"اعرف وبائك\" و\"المدخلات\" مروراً بـ\"المخرجات والنتائج\" (سلسلة رعاية المصابين بفيروس العوز المناعي البشري: الوقاية، وخدمات اختبار الفيروس، والرعاية، والعلاج بمضادات الفيروسات القهقرية، وكبت الحمل الفيروسي) وصولاً إلى \"تقييم الأثر\". وتُدرج تحته المؤشرات العالمية العشرة، من المتعايشين مع الفيروس والتمويل المحلي، مروراً بمعرفة الحالة والعلاج بمضادات الفيروسات القهقرية وكبت الحمل الفيروسي، إلى الوفيات المرتبطة بالإيدز والعدوى الجديدة، مع ثلاث علامات \"90\" تحت معرفة الحالة وتلقي العلاج وكبت الحمل الفيروسي.",
        "zh": "卫生部门艾滋病毒应对框架示意图，从“了解你的流行情况”和“投入”，经“产出和结果”（艾滋病毒关爱服务链：预防、艾滋病毒检测服务、艾滋病毒关爱、抗逆转录病毒治疗、病毒抑制），到“评价影响”。其下列出十项全球指标，从艾滋病毒感染者和国内供资，到知晓感染状况、抗逆转录病毒治疗和病毒抑制，再到艾滋病相关死亡和艾滋病毒新感染，在知晓状况、接受抗逆转录病毒治疗和病毒抑制下方各标有“90”。",
        "es": "Diagrama del marco de la respuesta del sector de la salud al VIH, que va de «Conozca su epidemia» e «Insumos» a «Productos y resultados» (la cascada de atención del VIH: prevención, servicios de pruebas del VIH, atención del VIH, tratamiento antirretroviral, supresión viral) y a «Evaluar el impacto». Debajo se enumeran los diez indicadores mundiales, desde las personas con VIH y la financiación nacional, pasando por el conocimiento del estado serológico, el tratamiento antirretroviral y la supresión viral, hasta las muertes relacionadas con el sida y las nuevas infecciones por el VIH, con tres marcas «90» bajo el conocimiento del estado, el tratamiento antirretroviral y la supresión viral.",
        "fr": "Schéma du cadre de la riposte du secteur de la santé au VIH, allant de « Connaître son épidémie » et des « Intrants » aux « Produits et résultats » (la cascade de soins du VIH : prévention, services de dépistage du VIH, soins du VIH, traitement antirétroviral, suppression virale) puis à « Évaluer l’impact ». En dessous figurent les dix indicateurs mondiaux, des personnes vivant avec le VIH et du financement national, en passant par la connaissance du statut sérologique, le traitement antirétroviral et la suppression virale, jusqu’aux décès liés au sida et aux nouvelles infections à VIH, avec trois repères « 90 » sous la connaissance du statut, le traitement antirétroviral et la suppression virale.",
        "ru": "Схема рамочной основы ответных мер сектора здравоохранения на ВИЧ: от «Знай свою эпидемию» и «Ресурсов» через «Результаты и итоги» (каскад помощи при ВИЧ: профилактика, услуги тестирования на ВИЧ, помощь при ВИЧ, антиретровирусная терапия, вирусная супрессия) к «Оценке воздействия». Ниже перечислены десять глобальных показателей — от числа людей, живущих с ВИЧ, и внутреннего финансирования через знание ВИЧ-статуса, антиретровирусную терапию и вирусную супрессию до смертей от СПИДа и новых случаев инфицирования ВИЧ; под знанием статуса, получением антиретровирусной терапии и вирусной супрессией стоят три отметки «90»."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-9",
      "file": "images/img-p011-9.webp",
      "page": 11,
      "narratives": {
        "en": "Line-drawing icon of a motor scooter, used in Fig. 2 to represent the motorbike riders who transport samples and results between health facilities and laboratory hubs.",
        "ar": "أيقونة مرسومة بالخطوط لدراجة نارية صغيرة (سكوتر)، تُستخدم في الشكل 2 لتمثيل سائقي الدراجات النارية الذين ينقلون العينات والنتائج بين المرافق الصحية ومراكز المختبرات.",
        "zh": "摩托踏板车的线描图标，在图2中代表在卫生机构与实验室中心之间运送样本和结果的摩托车骑手。",
        "es": "Icono dibujado a línea de una motocicleta tipo escúter, utilizado en la figura 2 para representar a los motoristas que transportan muestras y resultados entre los establecimientos de salud y los centros de laboratorio.",
        "fr": "Icône dessinée au trait d’un scooter, utilisée dans la figure 2 pour représenter les motocyclistes qui transportent les échantillons et les résultats entre les établissements de santé et les laboratoires centraux régionaux (hubs).",
        "ru": "Контурная иконка мотороллера, используемая на рисунке 2 для обозначения мотоциклистов, доставляющих образцы и результаты между медицинскими учреждениями и лабораторными узлами."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-10",
      "file": "images/img-p011-10.webp",
      "page": 11,
      "narratives": {
        "en": "Line-drawing icon of a house with a porch and steps, used in the Fig. 2 map of the sample transport network.",
        "ar": "أيقونة مرسومة بالخطوط لمنزل له شرفة ودرجات، مستخدمة في خريطة شبكة نقل العينات في الشكل 2.",
        "zh": "带门廊和台阶的房屋线描图标，用于图2的样本运输网络图。",
        "es": "Icono dibujado a línea de una casa con porche y escalones, utilizado en el mapa de la red de transporte de muestras de la figura 2.",
        "fr": "Icône dessinée au trait d’une maison avec un porche et des marches, utilisée dans la carte du réseau de transport des échantillons de la figure 2.",
        "ru": "Контурная иконка дома с крыльцом и ступенями, используемая на схеме сети транспортировки образцов на рисунке 2."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-11",
      "file": "images/img-p011-11.webp",
      "page": 11,
      "narratives": {
        "en": "Illustration of a laboratory worker wearing a face mask and lab coat looking into a microscope, representing the laboratory in the Fig. 2 transport-network map.",
        "ar": "رسم توضيحي لعاملة مختبر ترتدي كمامة ومعطف مختبر وتنظر في مجهر، يمثل المختبر في خريطة شبكة النقل في الشكل 2.",
        "zh": "一名戴口罩、穿实验服的实验室工作人员正在使用显微镜的插图，在图2的运输网络图中代表实验室。",
        "es": "Ilustración de una persona que trabaja en el laboratorio, con mascarilla y bata, mirando por un microscopio; representa el laboratorio en el mapa de la red de transporte de la figura 2.",
        "fr": "Illustration d’une personne travaillant en laboratoire, portant un masque et une blouse, qui regarde dans un microscope ; elle représente le laboratoire dans la carte du réseau de transport de la figure 2.",
        "ru": "Иллюстрация: лаборант в маске и лабораторном халате смотрит в микроскоп; обозначает лабораторию на схеме транспортной сети на рисунке 2."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-12",
      "file": "images/img-p011-12.webp",
      "page": 11,
      "narratives": {
        "en": "Icon of a blue post box labelled “POST”, representing the return of results by post in the Fig. 2 transport-network map.",
        "ar": "أيقونة صندوق بريد أزرق مكتوب عليه “POST”، تمثل إعادة النتائج عن طريق البريد في خريطة شبكة النقل في الشكل 2.",
        "zh": "标有“POST”的蓝色邮筒图标，在图2的运输网络图中代表通过邮寄返回结果。",
        "es": "Icono de un buzón de correos azul con la palabra «POST», que representa la devolución de resultados por correo en el mapa de la red de transporte de la figura 2.",
        "fr": "Icône d’une boîte aux lettres bleue portant l’inscription « POST », représentant le retour des résultats par la poste dans la carte du réseau de transport de la figure 2.",
        "ru": "Иконка синего почтового ящика с надписью «POST», обозначающая возврат результатов по почте на схеме транспортной сети на рисунке 2."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-16",
      "file": "images/img-p011-16.webp",
      "page": 11,
      "narratives": {
        "en": "Line-drawing icon of a motor scooter, used in Fig. 2 to represent the motorbike riders who transport samples and results between health facilities and laboratory hubs.",
        "ar": "أيقونة مرسومة بالخطوط لدراجة نارية صغيرة (سكوتر)، تُستخدم في الشكل 2 لتمثيل سائقي الدراجات النارية الذين ينقلون العينات والنتائج بين المرافق الصحية ومراكز المختبرات.",
        "zh": "摩托踏板车的线描图标，在图2中代表在卫生机构与实验室中心之间运送样本和结果的摩托车骑手。",
        "es": "Icono dibujado a línea de una motocicleta tipo escúter, utilizado en la figura 2 para representar a los motoristas que transportan muestras y resultados entre los establecimientos de salud y los centros de laboratorio.",
        "fr": "Icône dessinée au trait d’un scooter, utilisée dans la figure 2 pour représenter les motocyclistes qui transportent les échantillons et les résultats entre les établissements de santé et les laboratoires centraux régionaux (hubs).",
        "ru": "Контурная иконка мотороллера, используемая на рисунке 2 для обозначения мотоциклистов, доставляющих образцы и результаты между медицинскими учреждениями и лабораторными узлами."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-17",
      "file": "images/img-p011-17.webp",
      "page": 11,
      "narratives": {
        "en": "Icon of a health facility: a simple building outline with a red cross on the roof, used in the Fig. 2 transport-network map.",
        "ar": "أيقونة مرفق صحي: مخطط بسيط لمبنى عليه صليب أحمر، مستخدمة في خريطة شبكة النقل في الشكل 2.",
        "zh": "卫生机构图标：屋顶带红十字的简单建筑轮廓，用于图2的运输网络图。",
        "es": "Icono de un establecimiento de salud: contorno sencillo de un edificio con una cruz roja en el tejado, utilizado en el mapa de la red de transporte de la figura 2.",
        "fr": "Icône d’un établissement de santé : contour simple d’un bâtiment surmonté d’une croix rouge, utilisée dans la carte du réseau de transport de la figure 2.",
        "ru": "Иконка медицинского учреждения: простой контур здания с красным крестом на крыше, используемая на схеме транспортной сети на рисунке 2."
      },
      "state": "draft"
    },
    {
      "id": "img-p011-21",
      "file": "images/img-p011-21.webp",
      "page": 11,
      "narratives": {
        "en": "Icon of a health facility: a simple building outline with a red cross on the roof, used in the Fig. 2 transport-network map.",
        "ar": "أيقونة مرفق صحي: مخطط بسيط لمبنى عليه صليب أحمر، مستخدمة في خريطة شبكة النقل في الشكل 2.",
        "zh": "卫生机构图标：屋顶带红十字的简单建筑轮廓，用于图2的运输网络图。",
        "es": "Icono de un establecimiento de salud: contorno sencillo de un edificio con una cruz roja en el tejado, utilizado en el mapa de la red de transporte de la figura 2.",
        "fr": "Icône d’un établissement de santé : contour simple d’un bâtiment surmonté d’une croix rouge, utilisée dans la carte du réseau de transport de la figure 2.",
        "ru": "Иконка медицинского учреждения: простой контур здания с красным крестом на крыше, используемая на схеме транспортной сети на рисунке 2."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p011",
      "file": "figures/vfig-p011.webp",
      "page": 11,
      "shows": [
        "Figure 2"
      ],
      "narratives": {
        "en": "Illustrated diagram of a sample transport network: samples travel by motorcycle from a cluster of health facilities to a site gathering samples and results from the catchment area (such as a lab hub), then on to a central lab. Results return along the reverse path, and can be sent to facilities by post or delivered to sites.",
        "ar": "رسم توضيحي لشبكة نموذجية لنقل العينات: تُنقل العينات بالدراجة النارية من مجموعة من المرافق الصحية إلى موقع لتجميع العينات والنتائج من منطقة التغطية (مثل مركز مختبري)، ثم إلى مختبر مركزي. وتعود النتائج عبر المسار العكسي، ويمكن إرسالها إلى المرافق بالبريد أو تسليمها إلى المواقع.",
        "zh": "样本运输网络示例图：样本由摩托车从一组卫生机构运送至收集辖区内各机构样本和结果的地点（如实验室枢纽），再送往中心实验室。结果沿反向路径返回，可通过邮寄发送给机构或送达各点。",
        "es": "Diagrama ilustrado de una red de transporte de muestras: las muestras van en motocicleta desde un grupo de establecimientos de salud a un sitio que reúne muestras y resultados de la zona de captación (como un centro de laboratorio) y luego a un laboratorio central. Los resultados vuelven por el camino inverso y pueden enviarse a los establecimientos por correo o entregarse en los sitios.",
        "fr": "Schéma illustré d’un exemple de réseau de transport : les échantillons sont acheminés à moto d’un groupe d’établissements de santé vers un site regroupant échantillons et résultats de la zone de desserte (tel qu’un pôle de laboratoire), puis vers un laboratoire central. Les résultats reviennent par le chemin inverse et peuvent être envoyés aux établissements par la poste ou livrés sur les sites.",
        "ru": "Иллюстрированная схема примерной транспортной сети: образцы доставляются на мотоцикле из группы медицинских учреждений в пункт сбора образцов и результатов с обслуживаемой территории (например, лабораторный узел), а затем в центральную лабораторию. Результаты возвращаются обратным путём и могут направляться в учреждения по почте или доставляться на места."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p012",
      "file": "figures/vfig-p012.webp",
      "page": 12,
      "shows": [
        "Figure 3"
      ],
      "narratives": {
        "en": "Flow diagram of high-level standard operating procedures for viral load data, moving from \"Facility\" (test ordered, sample collected and dispatched) to \"Hub\", \"Central hub\" (data entry, testing, results sent), back to \"Hub\" and \"Facility\" (results received, transferred to site tools, cross-checked, reviewed), and up to \"Subnational and national\" levels (aggregation in DHIS2, review, data quality checks). Each step names the relevant monitoring and evaluation tools, such as requisition forms, specimen transport logs, laboratory information management systems and antiretroviral therapy registers.",
        "ar": "مخطط انسيابي لإجراءات التشغيل الموحدة الرفيعة المستوى لبيانات الحمل الفيروسي، ينتقل من \"المرفق\" (طلب الاختبار، وجمع العينة وإرسالها) إلى \"المركز\" ثم \"المركز الرئيسي\" (إدخال البيانات والاختبار وإرسال النتائج)، ثم يعود إلى \"المركز\" و\"المرفق\" (استلام النتائج ونقلها إلى أدوات الموقع ومطابقتها ومراجعتها)، ويصعد إلى المستويين \"دون الوطني والوطني\" (التجميع في DHIS2 والمراجعة وفحوص جودة البيانات). وتذكر كل خطوة أدوات الرصد والتقييم المعنية، مثل استمارات الطلب وسجلات نقل العينات ونظم إدارة المعلومات المختبرية وسجلات العلاج بمضادات الفيروسات القهقرية.",
        "zh": "病毒载量数据高层级标准操作程序流程图：从“机构”（开具检测、采集并发送样本）到“枢纽”、“中心枢纽”（数据录入、检测、发送结果），再回到“枢纽”和“机构”（接收结果、转入站点工具、交叉核对、审查），并上报至“地方和国家”层级（在DHIS2中汇总、审查、数据质量检查）。每一步都注明相关监测与评价工具，如申请单、样本运输日志、实验室信息管理系统和抗逆转录病毒治疗登记册。",
        "es": "Diagrama de flujo de procedimientos operativos normalizados de alto nivel para los datos de carga viral, que pasa de «Establecimiento» (solicitud de prueba, toma y envío de la muestra) a «Centro» y «Centro central» (registro de datos, análisis, envío de resultados), vuelve a «Centro» y «Establecimiento» (recepción de resultados, traslado a las herramientas del sitio, verificación cruzada, examen) y sube a los niveles «Subnacional y nacional» (agregación en DHIS2, examen, controles de calidad de los datos). Cada paso indica las herramientas de seguimiento y evaluación pertinentes, como formularios de solicitud, registros de transporte de muestras, sistemas de gestión de información de laboratorio y registros de tratamiento antirretroviral.",
        "fr": "Diagramme de flux des procédures opérationnelles normalisées de haut niveau pour les données de charge virale, allant de l’« Établissement » (prescription du test, prélèvement et expédition de l’échantillon) au « Pôle » puis au « Pôle central » (saisie des données, analyse, envoi des résultats), revenant au « Pôle » et à l’« Établissement » (réception des résultats, transfert dans les outils du site, contre-vérification, examen) et remontant aux niveaux « infranational et national » (agrégation dans DHIS2, examen, contrôles de la qualité des données). Chaque étape cite les outils de suivi et d’évaluation correspondants, tels que formulaires de demande, registres de transport des échantillons, systèmes de gestion de l’information de laboratoire et registres du traitement antirétroviral.",
        "ru": "Блок-схема стандартных операционных процедур высокого уровня для данных о вирусной нагрузке: от «Учреждения» (назначение теста, забор и отправка образца) к «Узлу» и «Центральному узлу» (ввод данных, тестирование, отправка результатов), обратно к «Узлу» и «Учреждению» (получение результатов, перенос в инструменты на местах, перекрёстная проверка, анализ) и далее на «субнациональный и национальный» уровни (агрегирование в DHIS2, анализ, проверка качества данных). Для каждого шага указаны соответствующие инструменты мониторинга и оценки: бланки направлений, журналы транспортировки образцов, лабораторные информационные системы и регистры антиретровирусной терапии."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p013",
      "file": "figures/vfig-p013.webp",
      "page": 13,
      "shows": [
        "Figure 4"
      ],
      "narratives": {
        "en": "Two boxed lists of key variables for laboratory forms. \"Specimen requisition form (entered at the clinic)\" lists items such as patient identification number, collection site, date of birth, sex, pregnancy or breastfeeding, current antiretroviral regimen, reason for the test, specimen type and adherence assessment; \"Testing requisition form (entered at the laboratory)\" lists demographic information, the viral load result and assay, specimen quality, temperature on receipt, and the dates of receipt, testing and reporting.",
        "ar": "قائمتان في إطارين بالمتغيرات الرئيسية للاستمارات المختبرية. تتضمن \"استمارة طلب العينة (تُعبأ في العيادة)\" بنوداً مثل رقم تعريف المريض، وموقع الجمع، وتاريخ الميلاد، والجنس، والحمل أو الرضاعة الطبيعية، ونظام العلاج الحالي بمضادات الفيروسات القهقرية، وسبب الاختبار، ونوع العينة، وتقييم الالتزام بالعلاج؛ وتتضمن \"استمارة طلب الاختبار (تُعبأ في المختبر)\" المعلومات الديمغرافية، ونتيجة الحمل الفيروسي ونوع الاختبار، وجودة العينة، ودرجة الحرارة عند الاستلام، وتواريخ الاستلام والاختبار والإبلاغ.",
        "zh": "两个方框列出实验室表格的关键变量。“样本申请单（在诊所填写）”包括患者识别号、采集地点、出生日期、性别、是否怀孕或哺乳、当前抗逆转录病毒治疗方案、检测原因、样本类型和依从性评估等；“检测申请单（在实验室填写）”包括人口学信息、病毒载量结果及检测方法、样本质量、接收时温度以及接收、检测和报告日期。",
        "es": "Dos listas en recuadros con las variables clave de los formularios de laboratorio. «Formulario de solicitud de muestra (cumplimentado en el consultorio)» incluye elementos como número de identificación del paciente, lugar de toma, fecha de nacimiento, sexo, embarazo o lactancia, pauta antirretroviral actual, motivo de la prueba, tipo de muestra y evaluación de la adherencia; «Formulario de solicitud de prueba (cumplimentado en el laboratorio)» incluye información demográfica, el resultado de carga viral y el ensayo, la calidad de la muestra, la temperatura a la recepción y las fechas de recepción, análisis y notificación.",
        "fr": "Deux listes encadrées des variables clés des formulaires de laboratoire. Le « Formulaire de demande d’échantillon (rempli au dispensaire) » comprend notamment le numéro d’identification du patient, le site de prélèvement, la date de naissance, le sexe, la grossesse ou l’allaitement, le schéma antirétroviral actuel, le motif du test, le type d’échantillon et l’évaluation de l’observance ; le « Formulaire de demande d’analyse (rempli au laboratoire) » comprend les informations démographiques, le résultat de charge virale et le test utilisé, la qualité de l’échantillon, la température à la réception et les dates de réception, d’analyse et de communication du résultat.",
        "ru": "Два списка в рамках с ключевыми переменными лабораторных форм. «Бланк направления на образец (заполняется в клинике)» включает, в частности, идентификационный номер пациента, место забора, дату рождения, пол, беременность или грудное вскармливание, текущую схему антиретровирусной терапии, причину теста, тип образца и оценку приверженности лечению; «Бланк направления на тестирование (заполняется в лаборатории)» включает демографические сведения, результат вирусной нагрузки и метод анализа, качество образца, температуру при получении, а также даты получения, тестирования и сообщения результата."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p018",
      "file": "figures/vfig-p018.webp",
      "page": 18,
      "shows": [
        "Figure 5"
      ],
      "narratives": {
        "en": "Stepped cascade diagram of routine viral load testing for people living with HIV receiving antiretroviral therapy, with successively smaller bars: all receiving therapy; those requiring at least one routine annual viral load test; those with access to testing; those who received a test; those with suppressed viral loads; and, finally, those with suppressed viral loads referred to a less intensive model of care.",
        "ar": "مخطط سلسلي متدرج لاختبار الحمل الفيروسي الروتيني للمتعايشين مع فيروس العوز المناعي البشري الذين يتلقون العلاج بمضادات الفيروسات القهقرية، بأعمدة تتناقص تدريجياً: جميع متلقي العلاج؛ ومن يحتاجون إلى اختبار روتيني سنوي واحد على الأقل للحمل الفيروسي؛ ومن تتاح لهم إمكانية الاختبار؛ ومن خضعوا للاختبار؛ ومن لديهم حمل فيروسي مكبوت؛ وأخيراً من لديهم حمل فيروسي مكبوت وأُحيلوا إلى نموذج رعاية أقل كثافة.",
        "zh": "接受抗逆转录病毒治疗的艾滋病毒感染者常规病毒载量检测阶梯式关爱链图，柱条依次递减：所有接受治疗者；需要每年至少一次常规病毒载量检测者；可获得检测者；已接受检测者；病毒载量受抑制者；最后是病毒载量受抑制并转介至强度较低的关爱模式者。",
        "es": "Diagrama escalonado de la cascada de pruebas rutinarias de carga viral para personas con VIH en tratamiento antirretroviral, con barras cada vez menores: todas las que reciben tratamiento; las que requieren al menos una prueba rutinaria anual de carga viral; las que tienen acceso a las pruebas; las que se hicieron la prueba; las que tienen carga viral suprimida; y, por último, las que tienen carga viral suprimida y fueron derivadas a un modelo de atención menos intensivo.",
        "fr": "Schéma en escalier de la cascade du dépistage systématique de la charge virale chez les personnes vivant avec le VIH sous traitement antirétroviral, avec des barres de plus en plus petites : toutes les personnes sous traitement ; celles nécessitant au moins un test annuel systématique de charge virale ; celles ayant accès au test ; celles ayant reçu un test ; celles dont la charge virale est supprimée ; et enfin celles dont la charge virale est supprimée et qui sont orientées vers un modèle de soins moins intensif.",
        "ru": "Ступенчатая каскадная схема планового тестирования на вирусную нагрузку у людей, живущих с ВИЧ и получающих антиретровирусную терапию, с последовательно уменьшающимися столбцами: все получающие терапию; нуждающиеся как минимум в одном плановом ежегодном тесте; имеющие доступ к тестированию; прошедшие тест; с подавленной вирусной нагрузкой; и, наконец, с подавленной вирусной нагрузкой, направленные на менее интенсивную модель помощи."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p019",
      "file": "figures/vfig-p019.webp",
      "page": 19,
      "shows": [
        "Figure 6"
      ],
      "narratives": {
        "en": "Cascade diagram for people receiving antiretroviral therapy with a viral load ≥1000 copies/ml: those who received enhanced adherence counselling, then those who received a follow-up viral load test. The follow-up splits into those still ≥1000 copies/ml (in red), followed by those switched to a second-line regimen, and those with suppressed viral loads, who resume routine viral load testing (see Fig. 5).",
        "ar": "مخطط سلسلي للأشخاص الذين يتلقون العلاج بمضادات الفيروسات القهقرية ولديهم حمل فيروسي ≥1000 نسخة/مل: من تلقوا مشورة معززة بشأن الالتزام بالعلاج، ثم من خضعوا لاختبار متابعة للحمل الفيروسي. وتنقسم المتابعة إلى من بقي حملهم ≥1000 نسخة/مل (بالأحمر)، ويليهم من تحولوا إلى نظام علاج من الخط الثاني، ومن أصبح حملهم الفيروسي مكبوتاً فيستأنفون الاختبار الروتيني للحمل الفيروسي (انظر الشكل 5).",
        "zh": "病毒载量≥1000拷贝/毫升的抗逆转录病毒治疗者关爱链图：接受强化依从性咨询者，然后是接受随访病毒载量检测者。随访结果分为仍≥1000拷贝/毫升者（红色），其后是转换为二线方案者；以及病毒载量受抑制者，他们恢复常规病毒载量检测（见图5）。",
        "es": "Diagrama de cascada para personas en tratamiento antirretroviral con carga viral ≥1000 copias/ml: las que recibieron asesoramiento reforzado sobre la adherencia y luego las que se hicieron una prueba de seguimiento. El seguimiento se divide en las que siguen con ≥1000 copias/ml (en rojo), seguidas de las que cambiaron a una pauta de segunda línea, y las que lograron la supresión viral, que reanudan las pruebas rutinarias de carga viral (véase la fig. 5).",
        "fr": "Schéma en cascade pour les personnes sous traitement antirétroviral ayant une charge virale ≥1000 copies/ml : celles ayant reçu un conseil renforcé pour l’observance, puis celles ayant eu un test de charge virale de suivi. Le suivi se divise entre celles toujours à ≥1000 copies/ml (en rouge), suivies de celles passées à un schéma de deuxième intention, et celles dont la charge virale est supprimée, qui reprennent le dépistage systématique de la charge virale (voir fig. 5).",
        "ru": "Каскадная схема для людей, получающих антиретровирусную терапию, с вирусной нагрузкой ≥1000 копий/мл: получившие усиленное консультирование по приверженности, затем прошедшие повторный тест на вирусную нагрузку. Далее путь разделяется: те, у кого нагрузка остаётся ≥1000 копий/мл (красным), затем переведённые на схему второй линии; и те, у кого нагрузка подавлена, — они возвращаются к плановому тестированию (см. рис. 5)."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p020",
      "file": "figures/vfig-p020.webp",
      "page": 20,
      "shows": [
        "Figure 7"
      ],
      "narratives": {
        "en": "Bar chart example of a cascade for people with non-suppressed viral load, with six bars labelled 65 (100%), 23 (35%), 8 (12%), 15 (23%), 10 (67%) and 1 (10%). The bar category labels are not part of the image.",
        "ar": "مخطط بالأعمدة يمثل مثالاً على سلسلة رعاية الأشخاص الذين لم يُكبت لديهم الحمل الفيروسي، يضم ستة أعمدة قيمها 65 (100%) و23 (35%) و8 (12%) و15 (23%) و10 (67%) و1 (10%). ولا تظهر تسميات فئات الأعمدة في الصورة.",
        "zh": "病毒载量未受抑制者关爱链示例条形图，六根柱条分别标为65（100%）、23（35%）、8（12%）、15（23%）、10（67%）和1（10%）。图像中不含柱条类别标签。",
        "es": "Gráfico de barras de ejemplo de una cascada para personas sin supresión viral, con seis barras rotuladas 65 (100%), 23 (35%), 8 (12%), 15 (23%), 10 (67%) y 1 (10%). Las etiquetas de categoría de las barras no forman parte de la imagen.",
        "fr": "Exemple de graphique à barres d’une cascade pour les personnes dont la charge virale n’est pas supprimée, avec six barres indiquant 65 (100 %), 23 (35 %), 8 (12 %), 15 (23 %), 10 (67 %) et 1 (10 %). Les libellés des catégories ne figurent pas dans l’image.",
        "ru": "Пример столбчатой диаграммы каскада для людей с неподавленной вирусной нагрузкой: шесть столбцов с подписями 65 (100%), 23 (35%), 8 (12%), 15 (23%), 10 (67%) и 1 (10%). Подписи категорий в изображение не входят."
      },
      "state": "draft"
    },
    {
      "id": "img-p032-128",
      "file": "images/img-p032-128.webp",
      "page": 32,
      "narratives": {
        "en": "A yellow sad-face icon on the viral load results form, placed beside the result to flag an unsuppressed viral load.",
        "ar": "أيقونة وجه حزين أصفر على استمارة نتائج الحمل الفيروسي، موضوعة بجانب النتيجة للإشارة إلى حمل فيروسي غير مكبوت.",
        "zh": "病毒载量结果表上的黄色哭脸图标，置于结果旁，用于标示病毒载量未被抑制。",
        "es": "Icono amarillo de una cara triste en el formulario de resultados de carga viral, colocado junto al resultado para señalar una carga viral no suprimida.",
        "fr": "Icône jaune représentant un visage triste sur le formulaire de résultats de la charge virale, placée à côté du résultat pour signaler une charge virale non supprimée.",
        "ru": "Жёлтая иконка грустного лица на бланке результатов исследования вирусной нагрузки, размещённая рядом с результатом, чтобы отметить неподавленную вирусную нагрузку."
      },
      "state": "draft"
    },
    {
      "id": "img-p032-129",
      "file": "images/img-p032-129.webp",
      "page": 32,
      "narratives": {
        "en": "An oval rubber stamp on the results form reading “Central Public Health Laboratories, Ministry of Health, Virology Lab”, with a small coat of arms inside.",
        "ar": "ختم مطاطي بيضاوي على استمارة النتائج مكتوب عليه “Central Public Health Laboratories, Ministry of Health, Virology Lab” (المختبرات المركزية للصحة العامة، وزارة الصحة، مختبر الفيروسات)، وفي داخله شعار نبالة صغير.",
        "zh": "结果表上的椭圆形橡皮图章，文字为“Central Public Health Laboratories, Ministry of Health, Virology Lab”（中央公共卫生实验室，卫生部，病毒学实验室），内有一个小国徽。",
        "es": "Sello de caucho ovalado en el formulario de resultados con el texto «Central Public Health Laboratories, Ministry of Health, Virology Lab» (Laboratorios Centrales de Salud Pública, Ministerio de Salud, Laboratorio de Virología) y un pequeño escudo de armas en su interior.",
        "fr": "Tampon ovale apposé sur le formulaire de résultats, portant l’inscription « Central Public Health Laboratories, Ministry of Health, Virology Lab » (Laboratoires centraux de santé publique, Ministère de la Santé, laboratoire de virologie), avec de petites armoiries à l’intérieur.",
        "ru": "Овальный резиновый штамп на бланке результатов с надписью «Central Public Health Laboratories, Ministry of Health, Virology Lab» (Центральные лаборатории общественного здравоохранения, Министерство здравоохранения, вирусологическая лаборатория) и небольшим гербом внутри."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p047",
      "file": "figures/vfig-p047.webp",
      "page": 47,
      "narratives": {
        "en": "Indicator reference table (printed rotated) with columns for monitoring question, indicator, numerator and denominator, disaggregation, data sources and considerations, programme relevance and importance, and indicator guidance source. Its two rows cover the percentage of people receiving antiretroviral therapy with viral load ≥1000 copies/mL who received a follow-up viral load test within six months, and the percentage who then suppressed to <1000 copies/mL on follow-up testing.",
        "ar": "جدول مرجعي للمؤشرات (مطبوع بشكل مُدار) يتضمن أعمدة لسؤال الرصد، والمؤشر، والبسط والمقام، والتصنيف، ومصادر البيانات والاعتبارات، والأهمية البرامجية، ومصدر إرشادات المؤشر. ويتناول صفّاه نسبة متلقي العلاج بمضادات الفيروسات القهقرية ذوي الحمل الفيروسي ≥1000 نسخة/مل الذين خضعوا لاختبار متابعة خلال ستة أشهر، ونسبة من انخفض حملهم بعد ذلك إلى أقل من 1000 نسخة/مل في اختبار المتابعة.",
        "zh": "指标参考表（旋转排印），列包括监测问题、指标、分子和分母、分类、数据来源及注意事项、规划相关性及重要性以及指标指导来源。两行分别涉及病毒载量≥1000拷贝/毫升的抗逆转录病毒治疗者中在六个月内接受随访病毒载量检测的百分比，以及随后在随访检测中降至<1000拷贝/毫升的百分比。",
        "es": "Tabla de referencia de indicadores (impresa en sentido apaisado) con columnas para pregunta de seguimiento, indicador, numerador y denominador, desglose, fuentes de datos y consideraciones, pertinencia e importancia programática y fuente de orientación del indicador. Sus dos filas abarcan el porcentaje de personas en tratamiento antirretroviral con carga viral ≥1000 copias/ml que se hicieron una prueba de seguimiento en seis meses y el porcentaje que luego bajó a <1000 copias/ml en la prueba de seguimiento.",
        "fr": "Tableau de référence des indicateurs (imprimé à l’horizontale) avec des colonnes pour la question de suivi, l’indicateur, le numérateur et le dénominateur, la ventilation, les sources de données et considérations, la pertinence et l’importance pour le programme, et la source d’orientation de l’indicateur. Ses deux lignes portent sur le pourcentage de personnes sous traitement antirétroviral ayant une charge virale ≥1000 copies/ml qui ont eu un test de suivi dans les six mois, et le pourcentage dont la charge est ensuite descendue sous 1000 copies/ml au test de suivi.",
        "ru": "Справочная таблица показателей (напечатана с поворотом) со столбцами: вопрос мониторинга, показатель, числитель и знаменатель, дезагрегирование, источники данных и соображения, значимость для программы и источник руководства по показателю. Две строки касаются доли людей на антиретровирусной терапии с вирусной нагрузкой ≥1000 копий/мл, прошедших повторный тест в течение шести месяцев, и доли тех, у кого при повторном тесте нагрузка снизилась до <1000 копий/мл."
      },
      "state": "draft"
    }
  ],
  "tables": [
    {
      "label": "Table 1",
      "caption": "Table 1. Summary and suggestions to address key challenges in viral load monitoring and evaluation",
      "pages": [
        15
      ],
      "columns": [
        {
          "titles": "Challenge"
        },
        {
          "titles": "Suggestions"
        }
      ],
      "rows": [
        [
          "Using data from unlinked laboratory, facility and/ or national aggregate reporting systems",
          "• Map out the flow of samples and results to and from facilities • Identify key indicators for routine monitoring that align with viral load testing guidelines, clinical algorithms and standard operating procedures • Overlay key indicators on the flow map of samples and results to and from facilities • Ensure that monitoring and evaluation tools with appropriate fields are available to capture these data • Develop standard operating procedures, training materials, mentorship protocols and data quality assessment processes for laboratories, facilities, and strategic information and monitoring and evaluation staff for data capture; train staff in an interdisciplinary way so that all staff members understand each other’s roles in capturing data and how various systems will be used to monitor viral load testing and suppression rates • Pilot test all changes in tools and training materials to identify challenges before launching on a larger scale • If the laboratory information management system is primarily relied on for viral load monitoring and reporting, ensure that unique individuals can be tracked over time and that data are accurately reflected in patient charts and being used for patient management"
        ],
        [
          "Tracking and reporting viral load data on tests for individuals",
          "• Clarify which systems track tests and/or individuals • Assess the degree to which individuals and their outcomes can be tracked • Ensure that individuals can be identified through age groups and key clinical information such as pregnancy and breastfeeding status; populations such as pregnant and breastfeeding women would require particular focus since a lack of viral load suppression could threaten the prevention of mother-to-child transmission • Be clear about which indicators track tests for individuals (see Section 2 for more information) • Summarize the limitations with reporting tests and individuals; to the extent possible, develop methods to de-duplicate results to report on individuals • Ensure that monitoring and evaluation tools, systems and processes are designed to track individuals (such as consistently using unique identifiers) • Tracking coverage of individuals who routinely receive viral load tests to ensure that everyone who should receive a viral load test is receiving it"
        ],
        [
          "Tracking patients over time (including those with viral load ≥1000 copies/mL)",
          "• Determine the extent to which monitoring and evaluation systems can track cohort-based and cross-sectional groups of individuals over time (see Section 2 for more details) • Example of groups of individuals that require longitudinal tracking: – Cohorts of individuals who have been receiving antiretroviral therapy for specified periods of time receiving viral load tests and their results (longitudinal) – Individuals who do not have suppressed viral loads (longitudinal) • Assess the monitoring and evaluation tools, systems and processes to track all groups of individuals and revise them as needed; ensure that individuals with viral load >1000 copies/mL are tracked appropriately and switched to second-line therapy, if needed • Consider how pregnant and breastfeeding women will be tracked if they transfer between sites in the peripartum or postpartum period • Pilot test all changes to identify key challenges and issues before rolling out nationally"
        ],
        [
          "Tracking viral load coverage and viral load suppression rates for individuals",
          "• Be clear about tracking the number of individuals and tests along the cascade of viral load testing so that programmes are using the appropriate denominator to assess rates of both coverage and viral load suppression • For tracking viral load coverage, the denominator should be the number of people living with HIV receiving antiretroviral therapy for at least 12 months; this denominator may be disaggregated by age and sex, pregnant women, breastfeeding women and other subpopulations so that programmes can track viral load testing coverage among various subpopulations • For routine programme reporting on rates of viral load suppression, the denominator should be specifically defined as the number of individuals who received a viral load test; ideally, programmes should track a cascade: number of individuals currently receiving antiretroviral therapy, number who received a viral load test and number with suppressed viral loads. Further, programmes should review the data by various subpopulations"
        ],
        [
          "Estimating the need for viral load testing",
          "• Key data include the number of individuals new to and currently receiving antiretroviral therapy who should receive viral load tests in a 12-month period. Consider: – Individuals new to antiretroviral therapy who may require two tests in a 12-month period (six months after initiation and again at 12 months after initiation) – Repeat tests because the first viral load ≥1000 copies/mL; this will depend on viral load testing guidelines and the prevalence of viral suppression in key age groups and populations – The timing and location of when and where pregnant and breastfeeding women receive viral load tests"
        ]
      ],
      "narratives": {
        "en": "Five key challenges in viral load monitoring and evaluation (unlinked reporting systems, tracking tests versus individuals, tracking patients over time, tracking coverage and suppression rates, estimating testing need), each with suggested actions to address it.",
        "ar": "خمسة تحديات رئيسية في رصد الحمل الفيروسي وتقييمه (نظم إبلاغ غير مترابطة، وتتبّع الاختبارات مقابل الأفراد، وتتبّع المرضى بمرور الوقت، وتتبّع معدلات التغطية والكبت الفيروسي، وتقدير الحاجة إلى الاختبار)، مع إجراءات مقترحة لمعالجة كل منها.",
        "zh": "病毒载量监测与评价中的五项主要挑战（报告系统互不关联、追踪检测与个人的区别、长期追踪患者、追踪覆盖率和病毒抑制率、估算检测需求），以及针对每项挑战的建议措施。",
        "es": "Cinco desafíos clave en el seguimiento y la evaluación de la carga viral (sistemas de notificación no vinculados, seguimiento de pruebas frente a personas, seguimiento de pacientes a lo largo del tiempo, seguimiento de la cobertura y las tasas de supresión, estimación de la necesidad de pruebas), cada uno con medidas sugeridas para abordarlo.",
        "fr": "Cinq défis majeurs du suivi et de l’évaluation de la charge virale (systèmes de notification non reliés, suivi des tests par rapport aux personnes, suivi des patients dans le temps, suivi de la couverture et des taux de suppression, estimation des besoins en tests), chacun accompagné de mesures suggérées pour y répondre.",
        "ru": "Пять ключевых проблем мониторинга и оценки вирусной нагрузки (несвязанные системы отчётности, учёт тестов и отдельных лиц, наблюдение за пациентами во времени, учёт охвата и уровня вирусной супрессии, оценка потребности в тестировании) с предлагаемыми мерами по решению каждой из них."
      },
      "csv": "tables/table-1.csv"
    },
    {
      "label": "Table 2",
      "caption": "Table 2. Core indicators along the viral load testing cascade",
      "pages": [
        17
      ],
      "columns": [
        {
          "titles": "Key steps in the cascade of viral load testing"
        },
        {
          "titles": "Core indicators for routine monitoring (see Annex 5 for more detailed indicator information, including numerator and denominator guidance)"
        }
      ],
      "rows": [
        [
          "Order viral load test",
          "• % of sites in the specimen transport network that are submitting samples for viral load testing • Number of viral load tests submitted by sites to the laboratory and specimen transport network"
        ],
        [
          "Process viral load test sample",
          "• Number of viral load tests received by the laboratory from sites • Number of viral load tests run by the laboratory"
        ],
        [
          "Returned viral load test result",
          "• % of viral load tests results returned to sites within one month of the sample being taken"
        ],
        [
          "Coverage, documentation and outcome of viral load test result",
          "• % of people receiving antiretroviral therapy with viral load results at 12 months after initiating antiretroviral therapy [WHO: VLS.2] • % of people receiving antiretroviral therapy tested for viral load with level <1000 copies/mL at 12 months after antiretroviral therapy initiation [WHO: VLS.1] • % of people with a viral load result documented in the medical records and/or laboratory information systems within the past 12 months with a suppressed viral load (<1000 copies/mL) [PEPFAR MER: TX_PVLS] • % of people living with HIV receiving antiretroviral therapy who have suppressed viral loads [WHO VLS.3] • % of people living with HIV with suppressed viral loads (<1000 copies/mL) who have been referred to a less intense model of care or differentiated service delivery"
        ],
        [
          "Intervene on viral load test result if viral load ≥1000 copies/mL",
          "• % of people receiving antiretroviral therapy with viral load ≥1000 copies/mL who have received enhanced adherence counselling"
        ],
        [
          "Order follow-up viral load test if viral load ≥1000 copies/mL",
          "• % of people receiving antiretroviral therapy with viral load ≥1000 copies/mL who received a follow-up viral load test within 3–6 months after enhanced adherence counselling (or according to the national guidelines) • % of people receiving antiretroviral therapy who had viral load ≥1000 copies/mL and then had suppressed viral load <1000 copies/mL on follow-up testing"
        ],
        [
          "Modify antiretroviral therapy regimen after two consecutive results of viral load ≥1000 copies/mL",
          "• % of people living with HIV receiving antiretroviral therapy with two documented viral load test results ≥1000 copies/mL switched to second- or third-line antiretroviral therapy regimens"
        ]
      ],
      "narratives": {
        "en": "Core indicators for routine monitoring at each step of the viral load testing cascade, from ordering the test and processing samples through returning results, coverage and suppression, follow-up of viral load ≥1000 copies/mL and regimen switching.",
        "ar": "المؤشرات الأساسية للرصد الروتيني في كل خطوة من سلسلة اختبار الحمل الفيروسي، بدءاً من طلب الاختبار ومعالجة العينات مروراً بإرجاع النتائج والتغطية والكبت الفيروسي ومتابعة الحمل الفيروسي ≥1000 نسخة/مل وانتهاءً بتغيير النظام العلاجي.",
        "zh": "病毒载量检测级联各环节的常规监测核心指标，从开具检测和处理样本，到返回结果、覆盖率和病毒抑制、病毒载量≥1000拷贝/毫升的随访以及更换治疗方案。",
        "es": "Indicadores básicos para el seguimiento sistemático en cada etapa de la cascada de pruebas de carga viral, desde la solicitud de la prueba y el procesamiento de las muestras hasta la devolución de resultados, la cobertura y la supresión, el seguimiento de cargas virales ≥1000 copias/ml y el cambio de pauta.",
        "fr": "Indicateurs de base pour le suivi systématique à chaque étape de la cascade des tests de charge virale, de la prescription du test et du traitement des échantillons au retour des résultats, à la couverture et à la suppression, au suivi des charges virales ≥1000 copies/ml et au changement de schéma thérapeutique.",
        "ru": "Основные показатели планового мониторинга на каждом этапе каскада тестирования на вирусную нагрузку — от назначения теста и обработки образцов до возврата результатов, охвата и супрессии, последующего наблюдения при вирусной нагрузке ≥1000 копий/мл и смены схемы лечения."
      },
      "csv": "tables/table-2.csv"
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "not-extracted",
      "note": "split one section per page; no contents was trusted"
    },
    {
      "kind": "sections",
      "state": "partial",
      "count": 56,
      "note": "one per page, not by heading"
    },
    {
      "kind": "figures",
      "state": "found",
      "count": 18
    },
    {
      "kind": "tables",
      "state": "found",
      "count": 2
    },
    {
      "kind": "references",
      "state": "not-extracted",
      "note": "a references section is in the text (p25); its entries are not extracted"
    },
    {
      "kind": "glossary",
      "state": "not-extracted",
      "note": "a glossary section is in the text (p6); its entries are not extracted"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 56,
      "note": "56 of 56 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-324745"
  }
}
